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1Chapter 1. General Introduction
Summary
Active remodeling of the cytoskeleton has been proposed to contribute to the low
energy cost and maintenance of the sustained contraction in smooth muscle.  Using
confocal microscopy and standard immunohistochemical techniques, direct observation of
actin remodeling was studied in the contracting A7r5 cell in response to the diacylglycerol
(DAG) analog phorbol 12, 13 dibutyrate (PDBu).  $-actin was shown to exist in the resting
cell as parallel stress cables that extend across the cell.  Stimulation by PDBu resulted in a
sustained contraction that occurred in approximately eighty-five percent of the A7r5 cells. 
The initial contraction was not uniform, but primarily occurred in the axis parallel to the
$-actin cables.  During the latter portion of contraction shortening occurred in all axis. 
During contraction, the cells shortened without apparent compression of the $-actin fibers
or new cable formation, suggesting that $-actin fibers undergo active remodeling during
contraction.  Treatment of the cells with cytochalasin resulted in dissolution of fibers in
the central region of the cell and elongation of precontracted cells in the axis parallel to the
$-actin fibers, suggesting that the $-actin cytoskeleton may serve to hold the cell in the
contracted state.  In unstimulated cells, "-actin exists as series of stress fibers similar in
appearance to $-actin fibers.  In contrast, within ten minutes of  PDBu stimulation "-actin
disassembled and reassembled into intensely-staining column-like structures that extend
from the cell’s base.  The "-actin column-like structures demonstrate a strong
2colocalization with "-actinin suggesting that they may be homologous to dense bodies in
differentiated smooth muscle.  Smooth muscle myosin also undergoes remodeling, in a
manner very similar to "-actin.  Dual immunostaining for "-actin and smooth muscle
myosin indicate a strong colocalization of the two proteins in the resting cell.  However,
following PDBu stimulation there was a partial dissociation of myosin from "-actin. 
Treatment of cells with cytochalasin B or dissolution of the "-actin fibers with
thapsigargin resulted in similar patterns of staining for "-actin and myosin.  This suggests
that myosin is in association with "-actin and follows changes in "-actin structure during
contraction.  This work suggests that the "- and  $-actin domains in the A7r5 cells
undergo specific remodeling in A7r5 cells, and suggests a model in which $-actin
filaments undergo remodeling to hold the cell in the shortened state at low energy cost
while "-actin and myosin remodel into a configuration that allows maximal mechanical
advantage for contraction.         
Dissertation Organization
This dissertation is divided into five chapters.  This first chapter presents a
summary of the dissertation and a general literature review.  The next three chapters are
manuscripts either published, or prepared for publication and therefore appear in the style
of the indicated journal.  Chapter two is a manuscript that describes and discusses
differential remodeling of actin isoforms in the A7r5 smooth muscle cell.  Chapter three
details myosin remodeling and its association with the actin cytoskeleton.  Chapter four
3details the effects of specific kinase inhibition on the remodeling phenomenon in order to
begin the determination of the biochemical pathways involved in cytoskeletal remodeling. 
The final chapter contains a general discussion of the results from the three manuscripts
presented in the dissertation as well as recommendations for further research. 
Literature Review
Smooth muscle was named due to the lack of striations when visualized by light
microscopy.  Smooth muscle tissue exists as a closely packed arrangement of the fusiform
smooth muscle cells that contain a central nucleus.  Smooth muscle is present in several
organ systems throughout the body: gastrointestinal, ocular, reproductive, respiratory,
urinary, and vascular.  The function of smooth muscle is largely directed toward transport
or storage.  However, this diverse tissue does not function merely as a rigid conduit for
transport.  This is exemplified by the very dynamic contractile/relaxant responses of
smooth muscle of the vasculature in the regulation and maintenance of blood pressure
throughout the body.  There are many unexplained properties and phenomenon that have
been observed in this remarkable tissue.      
Differences in Smooth and Striated Muscle
It is widely thought that the basic biochemical and biophysical interactions of actin
and myosin are similar in smooth, skeletal and cardiac muscle, as described by the sliding
filament theory.  However, there are several observations that bring into question the direct
4applicability of the sliding filament theory in smooth muscle.  In striated muscle, active
force development is in direct proportion to the overlap of actin and myosin filaments
(Gordon et al., 1966).  Smooth muscle, which lacks a typical sarcomere arrangement, is
capable of generation of force that is as great as (Murphy, 1976) or greater than (Gabella,
1976) skeletal muscle.  Smooth muscle actin and myosin filaments are not as ordered as
striated muscle, and appear largely random in distribution within the cells (Rice et al.,
1970; Somylo, 1980).  It has been shown that actin filaments may be arranged in bundles
that allow up to 15 actin filaments to interact with each myosin filament.  The myosin
content, however, may be only 20% that of skeletal muscle (Murphy et al., 1974; Murphy
1976).  These differences in structure and contractile protein content suggest that there
may be mechanisms in smooth muscle in addition to sliding filament that provide 
biochemical or mechanical advantages during smooth muscle contraction.  
In addition to structural differences, smooth muscle demonstrates the unique ability
to slowly develop tension, and then maintain the tension for a considerable time period. 
This maintenance of tension occurs at energy levels that are about 0.35% that of tetanized
striated muscle (Paul, 1983).  The principal biochemical and biophysical events underlying
the initiation of contraction in smooth muscle have been observed to be similar to striated
muscle.  Stimulation of smooth muscle results in an elevation of intracellular calcium that
leads to activation of calmodulin.  The calcium-calmodulin complex then activates myosin
light chain kinase which results in  phosphorylation of Ser 19 on the myosin light chains. 
Upon phosphorylation of the myosin light chains, myosin ATPase activity, and subsequent
myosin/actin crossbridge formation and cycling occur.  However, it has been shown that
5slow force development, maintenance of tension (Driska et al., 1981), and velocity of
shortening (Merkel et al., 1990) are disassociated from myosin light chain phosphorylation
and myosin ATPase activity (Zhang and Moreland, 1994) in smooth muscle.  Also
noteworthy, it has been demonstrated that the phorbol ester-induced contraction can occur
in the absence of a detectable increase of intracellular Ca2+ (Nakajima et al., 1993) or
concomitantly increased myosin light chain phosphorylation (Singer and Baker, 1987).
A number of protein kinases not presently associated with the established smooth
muscle pathway of contraction have been shown to alter the contractile response.  It has
been shown that Protein Kinase C (PKC) is tonically activated in response to a variety of
contractile agonists (Haller et al., 1990; Singer et al., 1992) whereas, the inhibition or
down-regulation of this enzyme blocks or attenuates the contractile response to different
agonists (Merkel et al., 1991; Shimamoto et al., 1993; Wright and Hurn, 1994).  Also of
interest is the finding that the inhibition of tyrosine kinase (Di Salvo et al., 1993 ; Di Salvo
et al., 1994; Gokita et al., 1994; Sriuasta and St-Louis, 1997; Tolloczko et al., 2000;
Duarte et al., 1997) blocks contraction in smooth muscle to various agonists.  These
findings suggest an important role of this kinase in electromechanical coupling or the
direct activation of the contractile apparatus by Ca2+ in the cell (Di Salvo et al., 1993; Di
Salvo et al., 1994; Tolloczko et al., 2000; Gokida et al., 1994).  Finally, Rokolye and
Singer (2000) have shown that the inhibition of calmodulin kinase II (CAMK II) has
variable effects on early force development and tension maintenance depending on the
agonist used to activate contraction.  They concluded that KN-93, a calmodulin kinase II
inhibitor, may play a role in regulating maintained tension in activated smooth muscle and
6that this inhibition could be abolished by activation of PKC.  
Hypotheses to Explain Differences
Several hypotheses have been developed to explain specific smooth muscle
properties.  Van Buren and colleagues (1994,1995) proposed that smooth muscle myosin
may compensate for low density by generation of crossbridge forces that are 3 to 4 times
those produced by skeletal muscle under loaded conditions.  An increase in the “duty
cycle” or the time that myosin remains in contact with actin has also been suggested
(Uyeda et al., 1990).  Others have proposed that slow tension development reflects a
balance between MLCK and protein phosphatase in the phosphorylation
/dephosphorylation of myosin light chains (Somylo et al., 1989).  The identification of a
specific myosin light chain phosphatase (Shirazi et al., 1994) lends evidence for this
hypothesis.  Still others have suggested that specific proteins may regulate the maintained
contraction (Lash et al., 1986; Hemric and Chaloric, 1988; Adam et al., 1989).  This
review will focus on three mechanisms: latch hypothesis, myosin lability, and actin
remodeling. 
Latch Hypothesis
The latch hypothesis was first proposed by Dillon and colleagues (1981) and further
characterized by Hai and Murphy (1988, 1989) and Murphy (1989).  The hypothesis
suggests a “latch” state in which dephosphorylated myosin cross-bridges remain bound to
7actin and cycle slowly to account for slow tension generation and force maintenance.  Hai
and colleagues (1991) describe four states in which myosin can exist: (M), unattached
myosin; (AM), myosin bound to actin; (Mp), unbound myosin with phosphorylated MLC
20; and (AMp), phosphorylated myosin bound to actin.  The initial contraction is
dependent on high intracellular calcium and subsequent activation of myosin light chain
kinase (MLCK) and phosphorylation of the regulatory MLC.  This results in (Mp) which
quickly binds actin to form (AMp).  This results in a rapid initial shortening velocity of
contraction.  As calcium levels and myosin light chain phosphorylation decrease, there is
an increase in (AM) which maintains developed force while small amounts of myosin
remain in the (AMp) state and contribute to slow velocity development.  Mathematical
models have been developed that are consistent with the latch hypothesis (Walker et al.,
1994), however, there is little direct evidence for this hypothesis.  Recently, investigators
demonstrated that the slowing of velocity occurs when phosphorylation levels of myosin
are still rising which strongly argues against the validity of the latch hypothesis (Mitchell
et al., 2001).       
Myosin Lability
Schoenberg (1969) and Rice et al. (1970) first suggested thick filament evanescence in
smooth muscle based on electron microscopy and the observation that myosin filaments
appeared to be dissolved in the resting cell and formed upon contraction.  Several other
studies utilizing electron microscopy have indicated that myosin filaments increase in
length and number in response to contraction in the anococcygeus muscle but not in the
8taenia coli (Gillis et al., 1988, Godfrain-Debecker and Gillis, 1988; Xu et al., 1997)
suggesting that in some smooth muscle types myosin filament structure may be stable and
not labile.  However, studies utilizing electron microscopy must be examined carefully as
fixation techniques may alter thick filament structure (reviewed in Somlyo and Somlyo,
1992).
The series-to-parallel theory suggests that during smooth muscle contraction, there
is a plasticity in the myosin heavy chains.  Smooth muscle can adapt to different muscle
lengths by variation of the number of filaments in series (Kuo et al., 2001).  Lengthening
of the myosin fibers will cause a series-to-parallel transition, as numerous filaments in
series remodel into longer filaments in parallel (Pratusevich et al., 1995; Seow et al.,
2000).
In the original description of sliding filament theory it was proposed that muscles
with long sarcomeres would generate more force and have a slower velocity compared to
short sarcomeres (Huxley and Neidergerke, 1954).  This inverse relationship between
force and velocity is supported by investigation of arthropod muscle which containes
sarcomeres of different lengths (Jasper and Pezard, 1934; Jahromi and Atwood, 1969). 
Seow et al. (2000) demonstrated that from two seconds after the start of contraction to the
tissue force plateau, velocity decreases are exactly matched by force increases when force
was corrected for changes in activation as assessed by maximum power.  They also
concluded that a twofold change in velocity can be explained mathematically by a series-
to-parallel change in thick filament orientation without changing the cross-bridge cycling
rate.  Calculations indicate that a fifty-five percent increase in myosin filament length
9could accomplish this, which is in agreement with the sixty percent increase in filament
density observed by Godfrain-Debecker and Gillis (1988) in contracted cells.  
Myosin filament density has also been shown to decrease by twenty percent in
response to cyclic stretch and then recover to preoscillation levels during a subsequent
tetani (Kuo et al., 2001).  It is suggested that mechanical strain facilitates depolymerization
of myosin filaments and its subsequent reorganization to allow optimal interaction with
the thin filament over a range of lengths. 
Actin Remodeling
Recently, considerable interest has focused on the role of actin cytoskeletal
organization on smooth muscle contractile properties.  The ability to study the effects of
actin remodeling was first made possible by isolation of fungal metabolites which inhibit
actin polymerization.  Cytochalasins, from the Greek cyto, cell and chalasis, relaxation,
were isolated from cultures of Helminthosporium dematioideum and Metarchizium
anisoplia (Carter, 1967).  Cytochalasins were shown to induce dissolution of thin
filaments (Schroeder, 1970; Wessels et al., 1971) and these microfilaments were later
determined to be actin filaments (Spudich and Lin, 1972; Spudich, 1972).  Cooper (1987)
determined that the molecular mechanism of cytochalasin action was through binding to
the barbed or growing end of the actin filament and preventing the addition of subsequent
monomers.  Cytochalasins have been shown to inhibit smooth muscle contraction with no
effect on calcium currents, myosin light chain phosphorylation, or myosin ATPase activity
in the K+ deploarized tissue (Obara and Yabu, 1994).
10
  Wright and Hurn (1994) first demonstrated that the use of cytochalasin to inhibit
actin polymerization caused a selective blockade of the slow tension increase in rat aortic
smooth muscle.  They suggested that the slow tension development by smooth muscle
required a capability for dynamic remodeling of a portion of the actin cytoskeleton during
the interval of contraction.  Their conclusion has been supported by recent studies (Mehta
and Gunst, 1999) showing that inhibition of actin polymerization by latrunculin-A, which
complexes with free monomers and inactivates G-actin (Coue et al., 1987), depressed
force development without affecting myosin light chain phosphorylation.  Saito and
colleagues (1996) demonstrated that cytochalasins can block the contractions induced by
K+ deploarization , norepinepherine, and the Ca2+-independent PDB contraction with no
detectable effect on MLC phosphorylation or myosin ATPase activity.  Other work
(Wright and Battistella-Patterson, 1998) has shown that inhibition of actin polymerization
blocks calcium-dependent stress relaxation in vascular smooth muscle, suggesting that
active remodeling of the actin cytoskeleton may also serve to decrease cellular tension
following abrupt stretch.  Contraction of isolated tracheal smooth muscle has been shown
to decrease the amount of G-actin in the cell (Mehta and Gunst, 1999) suggesting
increased filament formation.  The addition of an actin stabilizing factor, phalloidin, was
shown to induce a decrease in isometric force generation and stiffness and increased
actomyosin ATPase activity with no change in myosin light chain phosphorylation levels
or maximum velocity of contraction (Jones et al., 1999) suggesting that stabilization of the
actin filaments increased tension costs.  Recently, Barany et al. (2001) demonstrated that
even in resting tissue actin is dynamic with polymerization/depolymerization occurring
11
and that stabilization may take place in the plateau of contraction.   Taken together, these
results suggest that  actin polymerization is essential for the contractile and stress relaxant
properties of smooth muscle, and that the effects of blocking polymerization cannot be
attributed to a simple loss in cytoskeletal structure but more accurately reflects inhibition
of dynamic actin cytoskeletal remodeling. 
Smooth Muscle Actin
Actin in smooth muscle is structurally similar to actin found in other tissue types. 
It has the same molecular weight, ability to polymerize, and ability to bind myosin and
activate myosin ATPase (Bray, 1972).  The actin content in smooth muscle is thirty to fifty
milligrams per gram wet weight or thirty to fifty percent of the noncollagenous proteins
present which is 0.9-1.6 millimolar in situ (Murphy et al., 1977; Hartshore, 1987).   In
muscle, actin exists in two forms.  The basic unit is the monomeric globular G-actin which
has a molecular weight of 42 KDa (Hartshore, 1987).  G-actin undergoes polymerization
to form filamentous F-actin and this polymerization, as in skeletal muscle, is dependent on
actin concentration, ambient temperature, and cell ionic conditions (Strzelecka-
Golaszewska et al., 1980).  Actin monomers contain a divalent cation binding site as well
as an adenosine nucleotide binding site.  If either of the binding sites are unoccupied, the
actin denatures.  Polymerization occurs when ATP binds G-actin and is subsequently
hydrolyzed to ADP and Pi and the ADP remains bound to F-actin (Estes et al., 1992).  The
divalent cation site can bind calcium or magnesium and while in monomeric form the
cations can exchange freely.  However, after G-actin monomers polymerize, the cation is
12
trapped within the protein (Strzelecka-Golaszewska et al., 1980; Barany et al., 1992).  
Smooth muscle and skeletal muscle actin are similar in their ability to activate
myosin ATPase as demonstrated by the finding that F-actin purified from either muscle
type showed no differences in activation (Marston and Smith, 1984).  Also, Harris and
Warshaw (1993) have demonstrated utilizing an in vitro motility assay that there was little
functional difference in smooth and skeletal actin and that motility depended on the type
of actin used.  The rigor complex of skeletal or smooth muscle F-actin and myosin is
similar with identical stochiometry (Prochniewicz and Strzelecka-Golaszewska, 1980).
  
Actin Isoforms in Smooth Muscle
 Actin isoforms demonstrate a ninety-five percent homology in their 375 amino acid
structure (Pollard and Cooper, 1986) with the most variability between isoforms being in
the amino-terminus (Herman, 1993; Vandekerckhove and Webber, 1981).  The amino-
terminus has been shown to be important structurally and is probably responsible for
specific isoform function (Cook et al., 1992).  In mammalian tissues, six actin isoforms
have been identified: "-skeletal, "-cardiac, "-vascular, (-enteric, (-cytoplasmic, and $-
cytoplasmic with each of the proteins expressed from separate genes (Vandekerckhove and
Webber, 1981; Reddy et al., 1990).  Four actin isoforms have been identified in vertebrate
smooth muscle: "- and (- contractile actin and $- and (- cytoskeletal actin (Kabsch and
Vandekerckhove, 1992).  The smooth muscle isoforms have been shown to be
compartmentalized, and this compartmentalization may reflect a segregation according to
13
function (Small, 1995).  Staining of the smooth muscle cell with an anti-$-actin antibody
indicated a diffuse network throughout the cell while "- and (-actin staining suggested
that these isoforms form stress fibers in association with myosin filaments (North et al.,
1994).  Actin isoform expression does not appear to be species specific, however tissue
specific expression has been noted.  Visceral smooth muscle has selective expression of (-
actin while in vascular smooth muscle the predominate contractile isoform is "-actin
(Fatigati and Murphy, 1984).  Alpha-actin expression is considered to be associated with
tonic smooth muscle while (-actin is found in phasic smooth muscle.  The $-isoform of
actin has been found in all smooth muscles examined and appears to be associated with the
structural cytoskeleton (North et al., 1994).  Isoform expression also changes with
development as cytoplasmic actin expression is decreased with an increase in either "- or
(-actin in maturing tissue (Eddinger and Murphy, 1991; Hirai and Hirabayashi, 1983). 
The recent development of the smooth muscle "- actin null mouse (Schildmeyer et al.,
2000) has provided several insights into actin isoform specific function.  Complete
knockout of the smooth muscle "-actin transcript and protein did not have an apparent
effect on development of the cardiovascular system.  a-Actin knockout mice did not have
any apparent difficulty in feeding and reproduction.  It was concluded that this was to be
expected as the (-actin isoform is predominant in these tissues.  However, aortas from the
knockout mice did not have the ability to contract in response to potassium depolarization. 
Furthermore, reduced blood pressure and blood flow was detected in the a-actin null
mouse.  Surprisingly, skeletal muscle "-actin expression was activated in these animals,
which may help to compensate the loss of smooth muscle a-actin (Schildmeyer et al.,
14
2000).          
Smooth Muscle Myosin
The smooth muscle myosin molecule consists of six polypeptide chains: a
combination of two heavy chains, two regulatory light chains, and two essential alkali light
chains.  The two heavy chains form a dimer which comprises the main body of the
molecule.  The amino terminus of each heavy chain exists as a globular head region that is
connected by an "-helical coiled rod.  The motor activity of the myosin molecule is
contained within the globular head, including the ATP and actin binding sites.  Each
globular head has an associated regulatory and an essential light chain.  The carboxy
terminus of the heavy chains end in a short amino acid sequence that is not believed to
exhibit an "-helical structure (Reviewed in Gunst, 1999).  Enzymatic cleavage of the
myosin molecule produces the soluble S-1 subfragment and the rod portion.  The S-1
fragment consists of the heavy chain globular heads, and the associated regulatory and
essential light chains (Ikebe and Hartsthorne,1985; Adelstein and Sellers, 1996) and has
proven invaluable in the study of myosin function.
The control of assembly of monomeric myosin molecules to myosin filaments was
determined to reside in a carboxy-terminal fragment of the SM-MHC comprised of 150
amino acid residues (Cross and Vandekerckhove, 1986).  New evidence suggests that 28
residues located in the C-terminus end of the coiled-coil domain of the myosin heavy
chain are the critical residues mitigating myosin filament formation (Ikebe et al., 2001).  It
has been suggested that a pool of monomeric myosin may be recruited to form myosin
15
filaments as myosin filament density has been shown to increase in some contracted
smooth muscle tissues (Xu et al., 1997;Watanabe et al., 1993; Gillis et al., 1988). 
Increases in excess of 61 myosin filaments per square micron were reported in rat
annococcygeus smooth muscle upon contraction (Gillis et al., 1988). Others have reported
increases in myosin filament densities ranging from 23% (Xu et al., 1997) to 106%
(Watanabe et al., 1993) in contracted muscle. In contrast, Horowitz and colleagues (1994)
detected only minute amounts of monomeric myosin in unstimulated muscle and
concluded that assembly/disassembly is unlikely to play a role in contraction.  Other
experimental approaches have implicated myosin assembly/disassembly during
contraction.  Phosphorylation of the 20KDa myosin light chain has been shown to favor
filamentous actin (Trybus, 1994; Suzuki et al. 1978). While dephosphorylation of the of
the MLC-20 may lead to disassembly of filaments, dephosphorylated filaments exist in a
relaxed smooth muscle (Somlyo et al., 1981).  In contract to other reports, Fultz et al.
(unpublished data) directly observed myosin filament disassembly during contraction and
subsequent reassembly of filament structure in association with alpha-actin at the
termination of contraction in cultured smooth muscle cells.  Their finding of closely
associated actin/myosin remodeling is supported by observations indicating that F-actin
can induce polymerization of monomeric myosin, and the selective disruption of F-actin
by sevrin resulted in an immediate disassembly of the myosin filaments (Applegate and
Pardee, 1992).  Intracellular calcium levels have also been linked to myosin filament
formation.  An increase in intracellular calcium induced a 144% increase in fiber density;
whereas, in the absence of intracellular calcium, myosin filament density decreased by
16
35% and returned to control levels upon the addition of physiological saline (Herrera et al.,
2002).  However, it is also reported that direct calcium binding by myosin leads to a less
ordered structure that is more pronounced with unphosphorylated myosin (Podlubnaya et
al., 1999).  Myosin heavy chain isoform composition has also been shown to play a role in
filament formation as SM1 and SM2 MHCs demonstrate variable solubilities and different
modes of molecular packaging suggesting that uncoiled tail-pieces may also play a role in
filament formation (Rovner et al. 2002). 
Smooth Muscle Myosin Heavy Chains
Three distinct types of myosin heavy chains have been shown to be expressed in
smooth muscle.  Two of these are non-muscle myosin heavy chains (NM-MHC) and the
third is smooth muscle specific myosin heavy chain (SM-MHC).  The NM-MHCs are
separate gene products designated NM-MHCA and NM-MHCB and have a molecular
mass of 196KDa and 198-200KDa  (Morano, 1992).  Alternate splicing 39 base-pairs of
the SM-MHC at the 3' end produces two isoforms of SM-MHC that differ in the length of
their carboxy terminus, the 204 KDa SM1 and the 200 KDa SM-2 (Nagai et al., 1989;
Babij and Periasamy, 1986).  Expression of these isoforms have been shown to be equal in
some smooth muscle tissues (Kelley et al., 1991; Kelley et al., 1993) but others have
reported unequal expression of the two isoforms (Rovner et al., 1986; Eddinger and Meer,
1997) and highly variable expression between smooth muscle cells from the same tissue
(Eddinger and Meer, 1997).  Changes in expression of SM-1 and SM-2 occur during
development.  The relative amount of SM-2 is increased, while SM-1 and NM-MHC both
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decrease.  The change in the ratio of expression of these various isoforms results in SM-2
being termed the“mature” SM-MHC isoform (Lin et al., 2000; Arens et al., 2000). 
Changes in the expression of these different isoforms are believed to occur as the result of
a  functional need for the specific tissue to be able to develop tension with maturity (Arens
et al., 2000).  In contrast, it has been reported that there is no relationship between SM-
1/SM-2 isoform expression and Vmax (Morano et al., 1993; Meer and Eddinger, 1997) and
that the different isoforms are indistinguishable in their ability to move actin filaments in
in vitro motility assays (Kelley et al., 1992).  Meer and Eddinger (1997) report that
isoform composition may play a role in final cell length after shortening and suggest that
SM-1 and SM-2 isoforms may affect filament length.  Ishibashi and Bukaski (1997)
correlated lowering of SM-2 isoform levels and a constant level of SM-1 with the loss of
force generated by tissue in culture.  Other studies have shown that cyclic stretch can
induce a four to six fold increase in SM-1 and SM-2 levels with a concurrent lowering of
NM-MHCA protein concentrations (Reusch et al., 1996). The issue of isoform function is
further complicated by the finding that the two isoforms may form SM-1/SM-2
heterodimers as well as SM-1 and SM-2 homodimers and that these dimer forms may
differ between cells in the same tissue (Tsao and Eddinger, 1993). However, Kelly et al.
(1992) found that only homodimers were formed.  Recently,  a smooth muscle myosin
heavy chain knockout mouse has been developed (Morano et al., 2000).  This model did
not express SM-1 or SM-2 but did appear to recruit NM-MHC for contraction.  In these
animals, the initial fast phase of contraction was absent while the slow, maintained phase
was identical to that in control mice suggesting that SM-MHC isoforms are only essential
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for the fast phase of contraction and the tissue has the ability to switch from one type to
another at different stages of contraction (Morano et al., 2000).  A second set of SM-MHC
isoforms have been identified that contains alternate splicing of a twenty-one-bp exon at
the 5' end of the transcript that encodes for seven amino acids in the globular head domain
near the ATP-binding site.  This results in the inserted (SM1B, SM2B) and non-inserted
(SM1A, SM2A) isoforms of the myosin heavy chain (Babij 1993; Kelley et al., 1993;
White et al., 1993).  The seven amino acid insertion appears to be mostly absent in
vascular smooth muscle.  SM-MHCs with the insert have been shown to have a two fold
increase in ATPase activity and moves actin filaments twice as fast as SM-MHcs lacking
the insert (Kelley et al., 1993; Rovner et al., 1997).  However it has been demonstrated
that SM-B expression alone cannot completely explain the differences in shortening
velocity (Eddinger and Meer, 2001).  Distribution of the SM-A and SM-B isoforms has
also shown to be nonuniform, even within the same tissue (Parisi and Eddinger, 2002;
Low et al., 1999).
 Due to the diversity and heterogenity in myosin heavy chain isoform expression
within tissue, the role of the MHC isoforms in the smooth muscle contraction remains
uncertain (Murphy et al., 1997).
Smooth Muscle Myosin Light Chains 
Two isoforms of the essential 17 KDa smooth muscle light chain have been
identified and designated LC17a and LC17b.  These isoforms differ in five of the last nine
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amino acids at their carboxy terminals (Lash et al., 1990; Nabeshima et al., 1987).  There
appears to be a correlation between the expression of LC17 isoforms and smooth muscle
contractile properties.  Faster contracting muscles such as those in the gastrointestinal tract
contain only LC17a, while the slower contracting smooth muscle of the aorta, pulmonary
and carotid arteries contain higher levels of LC17b (Helper et al., 1988; Molmquist and
Arner, 1991).  Exchange of the LC17a isoform into avian aortic smooth muscle did not
increase filament velocity in the in vitro motility assay (Kelley et al., 1993).  However,
transfer of LC17a into porcine aorta increased ATPase activity (Hasegawa and Morita,
1992) suggesting the effect of LC17a on filament velocity may be species specific.  More
recently, recombinant LC17a and LC17b expression has demonstrated that myosin
expressing LC17a has an increased rate of force development over tissues expressing
LC17b (Huang et al., 1999).  In addition, both an increase in shortening velocity and rate
of force development in response to trifluoperazine were shown with forced LC17a
expression (Matthew et al., 1988).  These studies suggest that the essential light chain 17
isoform composition of tissue may explain some of the differences in contractile properties
between phasic and tonic smooth muscle.
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Summary
It has been proposed that the reorganization of components of the actin cytomatrix could
contribute to force development and the low energy cost of sustained contraction in
contractile cells which lack a structured sarcomere (Battistella-Patterson et al., 1997). 
However, there has been no direct evidence of an apropos actin reorganization specifically
linked to the contractile response in cells of this type.  Remodeling of the "- and $-actin
domains was studied in A7r5 smooth muscle cells during phorbol 12, 13 dibutyrate
(PDB)-induced contraction using immunohistologic staining and $-actin-green fluorescent
protein ($-actin-GFP) fusion protein expression.  Cells stained with phalloidin as well as
cells expressing $-actin-GFP showed densely packed actin stress cables, arranged in
parallel and extending across the cell body.  PDB caused approximately 85% of cells to
contract with evidence of forcible detachment from peripheral adhesion sites seen in many
cells.  The contraction of the cell body was not uniform but occurred along a principal axis
parallel to the system of densely packed $-actin cables.  During the interval of contraction,
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the $-actin cables shortened without evidence of disassembly or new cable formation.  The
use of cytochalasin to inhibit actin polymerization resulted in the dissolution of the actin
cables at the central region of the cell and caused the elongation of precontracted cells.  In
unstimulated cells, "-actin formed cables similar in arrangement to the cell spanning $-
actin cables.  Within a short interval after PDB addition; however, the majority of "-actin
cables disassembled and reformed into intensely fluorescing column-like structures
extending vertically from the cell base at the center of clusters of "-actin filaments.  The
"-actin columns of contracting cells showed strong colocalization of "-actinin suggesting
they could be structurally analogous to the dense bodies of highly differentiated smooth
muscle cells.  The results indicate that the "- and $-actin domains of A7r5 cells undergo a
highly structured reorganization during PDB-induced contraction.  The extent and nature
of this restructuring suggest that remodeling could play a role in contractile function.
Introduction
It is widely accepted that the mechanism underlying the generation of force by cells
centers on the interaction of actin with myosin and that the principal biochemical and
biophysical events determining cellular contractile properties are generally similar among
different cell types.  Much of our understanding of how cells develop force stems from the
study of skeletal muscle in which the basic contractile unit, the sarcomere, is highly
structured and active force development is in direct proportion to the degree of overlap of
actin and myosin filaments (Gordon et al., 1966).  However, other types of contractile cells
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may lack a typical sarcomere arrangement but still exhibit the capability to generate force
at a level equal (Murphy, 1976) or greater (Gabella, 1976) than in skeletal muscle.  Within
this category of contractile cells, smooth muscle has been intensely studied and a wealth of
information is available pertaining to its contractile properties.   For example, smooth
muscle shows a uniform distribution of actin and myosin filaments within the cell
(reviewed in Small, 1995).  Other notable differences include the ability of smooth muscle
to slowly develop force and to sustain maximal tension for extended intervals at an energy
cost of about 0.35% that expended in comparable contractions of skeletal muscle (Paul,
1983).  Moreover, there is evidence suggesting that force development and maintained
tension (Driska et al., 1981) as well as velocity of shortening (Merkel et al., 1990) are
disassociated from myosin light chain phosphorylation and actin-activated myosin ATPase
activity (Zhang and Moreland, 1994) in smooth muscle.  Hence, there has been
considerable recent interest in additional factors that could contribute in modifying the
contractile properties of smooth muscle from that predicted solely on the basis of sliding
filament theory.
Several reports have documented the finding that different agents which inhibit actin
filament polymerization either block or significantly alter the contractile properties of
smooth muscle (Wright and Hurn, 1994; Battistella-Patterson et al., 1997; Wright and
Batistella-Patterson, 1998; Mehta and Gunst, 1999; Jones et al., 1999).  One explanation is
that the remodeling of the contractile domain of the actin cytomatrix could contribute to
the characteristics of active force development by effectively modulating this component
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at optimal mechanical advantage prior to and during cell shortening (Battistella-Patterson
et al., 1997).  It has been further suggested that crosslinking (Small et al., 1986) and
remodeling of the actin tension bearing fibers (Battistella-Patterson et al., 1997) could
contribute to the low energy cost of sustained tension maintenance by holding the cell in
the contracted configuration.
Despite speculation that cytoskeletal remodeling may play an important role in contractile
function, there is little direct evidence of active structural remodeling in smooth muscle
(Togashi et al., 1998).  To a considerable extent this paucity of information reflects the
small cell size and the apparent lack of structural order of the cytoskeleton in the
differentiated smooth muscle cell (Small and Gimona, 1998).  One approach to the study
of contractile function-related cytoskeletal organization is through the use of cell lines that
retain the ability to contract in cell culture.  For example, a number of structural and
biochemical similarities can be demonstrated in the actin cytoskeletal and contractile
domains of smooth muscle and fibroblasts (Sappino et al., 1990; Buoro et al., 1993)
suggesting that the study of different cell types could provide useful information
concerning contraction-linked remodeling phenomenon in the cytoskeleton.  In the present
study we utilized confocal microscopy with $-actin-enhanced green fluorescent protein ($-
actin-GFP) fusion protein expression and standard immunohistologic staining techniques
to investigate changes in the actin cytoskeleton in contracting A7r5 cells.   The results
indicate extensive and highly different modes of remodeling of the $-actin and "-actin
domains during phorbol 12,13 dibutyrate-induced cell contraction.  The findings provide
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initial insight into the extent and nature of the reorganization of the actin cytoskeleton of
contractile cells that do not have a highly structured arrangement of contractile proteins.
Materials and Methods
Cell Culture.   A7r5 cells, originally derived from embryonic rat aorta and exhibiting an
adult smooth muscle phenotype (Firulli et al., 1998) were obtained from American Type
Culture Collection (Manassas, VA) and cultured in Dulbecco’s modified Eagle’s medium
(DMEM) that was supplemented with 10% fetal bovine serum, 100 units/ml penicillin G,
and 100 µg/ml streptomycin.  Cells were plated onto 75 mm2 culture flasks and grown to
approximately 85% confluence.  Cultures were maintained at 37°C in a humidified
atmosphere of 5% CO2 in air.  The medium was changed every two days and the cells were
passaged at least once a week.  Cells were detached from the culture flask by the addition
of a trypsin/EDTA solution in HBSS.
$-actin-GFP Plasmid Transfection.  A $-actin-EGFP expression plasmid was purchased
from Clontech (Palo Alto, CA).  The green fluorescent protein-actin fusion protein has
been successfully utilized in a wide range of cell types (Noegel and Schleicher, 2000;
Okada et al., 1999; Verkhusa et al., 1999; Faix et al., 1998; Aizawa et al., 1997) and has
been shown to be a suitable probe for the study of actin organization and dynamics in
several mammalian cell lines (Choidas et al., 1998).  Cells were seeded at a density of 4 x
106 cells/100 mm2 culture flask and transfected with 2 to 6 µg of plasmid using
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lipofectamine (Life Technologies, Rockville, MD) according to the manufacturer’s
standard protocol.  Fluorescence of the $-actin-GFP fusion protein was typically observed
within 2 days and experiments were performed within 3 or 4 days after transfection.  
Confocal Microscopy.   In experiments employing cell immunostaining, A7r5 cells were
plated onto 22 mm by 22 mm #1 glass coverslips placed in 6 well culture plates and
returned to the incubator for a minimum of 24 hours to allow for cell attachment and
spreading.  Cells were fixed and permeabilized by the addition of ice cold acetone for 1
minute.  The cells were then washed multiple times (3X) with phosphate-buffered saline
(PBS) containing 0.5% TWEEN-20 (PBS-T); pH 7.5, and incubated for 10 minutes in
blocking solution (5% nonfat dry milk in PBS-T).  Cells were stained for "-actin by
incubation in a 1:500 dilution of monoclonal anti-"-smooth muscle actin clone 1A4 FITC-
labeled antibody (Sigma Chemical Co., St. Louis, MO) for 30 minutes at room
temperature.  For total F-actin staining, the fixed cells were incubated with 2.5 x 10-6M
TRITC-labeled phalloidin (Sigma Chemical Co., St. Louis, MO) for 30 minutes at room
temperature.  Cells were stained for $-actin by incubation in a 1:500 dilution of
monoclonal anti-$-actin clone AC-15 primary antibody (Sigma Chemical Co., St. Louis,
MO) for 30 minutes at room temperature followed by incubation with an Alexa 488
labeled secondary antibody (Molecular Probes, Eugene, OR).  The crosslinking protein "-
actinin was visualized by incubation of cells in a 1:200 dilution of monoclonal Anti-"-
Actinin primary antibody (Sigma Chemical Co., St. Louis, MO) followed by the addition
of Alexa 488-labeled secondary antibody (Molecular Probes, Eugene, OR).  In dual
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immunostaining experiments to study the colocalization of "-actin and "-actinin, Alexa
594-labeled secondary antibody (Molecular Probes, Eugene, OR) was substituted for the
Alexa 488-labeled antibody.  Stained cells or living cell preparations expressing $-actin-
GFP were visualized by mounting on a Nikon Diaphot Microscope and confocal
microscopy was performed with a BioRad Model 1024 Scanning system equipped with a
krypton/argon laser.  Micrographs were built by projecting serial Z-plane image
acquisitions and were analyzed using Lasersharp and Confocal Assistant software
(BioRad, Hercules, CA).
Cell Treatments.  Actin cytoskeletal reorganization was studied in A7r5 cells contracted
by the addition of 10-8 M phorbol 12,13 dibutyrate (PDB) to the incubation medium.  In
order to ensure that the results were not due to a nonspecific effect of PDB, control studies
were also conducted using the inactive 4"-phorbol 12,13-didecanoate (4" PDD) at
concentrations ranging to 10-6 M.  In ancillary experiments to examine the effects of
different agonists, the contractile response of A7r5 cells to A23187 (10-5 M), norepinephrine
(10-6 M), and angiotensin II (10-6 M) was also investigated.  In order to study the effects of
inhibiting actin polymerization, cytochalasin B (0.1 µg/ml) was added to the medium at
varying intervals prior to cell fixation or imaging.  
Data Analysis.  Each experiment was performed a minimum of three times with at least
50 cells from fixed preparations and 3 to 6 cells from live preparations evaluated per
experiment.  Results were confirmed by at least two observers and phenomenon were
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judged significant if observed in 80% or more cells.  Contractile shortening of cells in the
x- and y-axis was analyzed by two way ANOVA followed by Students t-test.  P < 0.05 was
considered significant.
Results
Figure 1 compares the contractile response to phorbol 12,13 dibutyrate (PDB) and the
calcium ionophore A23187 in A7r5 cells expressing $-actin-GFP fusion protein.  Both
agents were effective agonists, consistently causing approximately 85% of cells to visibly
contract.  Cell shortening in response to PDB could first be observed at about 10 minutes
and extended over an interval of approximately 60 minutes to completion.  Cell
constriction to PDB was extremely strong such that by 35 to 45 minutes the resolution of
individual actin filaments was no longer possible.  In consequence, cell imaging was
performed during the first 30 minutes following PDB addition, while individual actin
stress cables were clearly observed.  During this interval the pattern of cell constriction
was acentric with the principal axis of shortening (x-axis) parallel to the densely packed $-
actin stress cables spanning the cell body.  PDB-treated cells showed an average 34%
reduction of length in the x-axis (p < 0.05) while shortening in the y-axis was only 17% at
30 minutes (Fig. 2).  Veritcal displacement of cell volume was verified from analysis of Z-
plane images which indicated an average 46 ± 8% increase in cell height of PDB-treated
cells at 30 minutes.  By comparison, cells treated with A23187 showed a more rapid onset of
38
contraction with detectable shortening noted as early as 2.0 minutes and completion of
response recorded by 30 minutes in the majority of cells (Fig. 1).  The average length in
the x- and y- axes of A23187 treated cells at 30 minutes was 48 ± 10% and 62 ± 2% of the
pretreatment value, respectively.  Cells contracted by either agonist exhibited thread-like
extrusions and detached cell remnants on the glass substrate, indicating the forcible
detachment from peripheral adhesion sites.  Interestingly, A7r5 cells did not contract in the
presence of 10-6 M norepinephrine or 10-6 angiotensin II (data not shown) suggesting that,
while these cells were clearly responsive to the elevation of intracellular calcium (A23187)
and activation of PKC (PDB), they lacked the capability for receptor-mediated contraction
to at least these two agonists.
Figure 3 shows the time course of PDB-stimulated cell shortening with the accompanying
changes in the $-actin stress cables in A7r5 cell expressing $-actin-GFP.  The $-actin
cables shortened without evidence of significant compression throughout the interval in
which the length of the x-axis decreased.  Moreover, individual cables were identified
throughout the interval of contraction indicating that shortening was not accomplished by
disassembly and reassembly of new structure.  The use of cytochalasin B to block actin
filament polymerization caused the loss of actin stress cable integrity at the central region
of the cell (Fig. 4).  It was further noted that the treatment of precontracted cells to disrupt
actin stress cables caused a visible cellular elongation in the x-axis (Fig. 5), suggesting that
these structures contributed to holding the cell in the contracted configuration. 
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Staining PDB-stimulated cells with phalloidin verified the presence of an extensive system
of actin stress cables in contracted cells (Fig. 6).  In addition, these experiments revealed
the occurrence of discrete peripheral bodies that were absent in unstimulated cells. 
Because these structures were also not observed in contracted cells expressing $-actin-
GFP or in the cells stained with anti-$-actin antibody (Fig. 7), the results suggested that
they most likely represented a component of the "-actin domain.  Immunostaining of
unstimulated cells indicated that "-actin formed thick stress cables (Fig. 8) similar in
appearance to $-actin cables.  Upon stimulation with PDB; however, "-actin underwent a
dramatic reorganization that began to develop within 10 minutes, thus preceeding the first
observable shortening of PDB-treated cells.  Addition of PDB was followed by the loss of
the major portion of densely packed "-actin stress cables observed prior to cell stimulation
(Fig. 8).  Concurrent with the disassembly of "-actin stress cables, large numbers of
intensely staining bodies were observed to form at the cell periphery just inside the
membrane (Figs. 8, 9).  These peripheral structures were further observed to occur at
intervals along some of the few remaining "-actin cables or appeared as the focal point to
clusters of randomly oriented "-actin fibers.  An analysis of Z-series images indicated that
they extended column-like from the cell base toward the dorsal cell surface (Fig. 10). 
Interestingly, there was little or no evidence of compression of the "-actin cables and
filaments in the interval between 10 and 30 minutes (Fig. 8) suggesting that this domain
continued to remodel during the interval of cell constriction.  Figure 11 demonstrates that
neither the inactive phorbol ester 4" PDD nor norepinephrine, which did not cause
contraction of A7r5 cells, had an effect on "-actin remodeling.
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Immunostaining for "-actinin further indicated that this important actin crosslinking
protein underwent PDB-induced remodeling closely associated with that of "-actin (Fig.
12).  In unstimulated cells "-actinin staining was highly granular in appearance with the
protein organized into filamentous strands.  Within 10 minutes after treatment with PDB,
"-actinin reformed into intensely fluorescing peripheral bodies (Fig. 12) with some cells
also showing high levels of "-actinin at the subplasmalemma.  Dual immunostaining for
"-actin and "-actinin showed partial colocalization of the proteins in unstimulated cells
and clear evidence of close association of the two components in the column-like
peripheral structures of PDB-contracted cells (Fig. 13).
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Figure 1 The contractile response of A7r5 cells to phorbol 12,13dibutyrate (PDB)
and the calcium ionophore A23187.  Cells were transfected with a $-actin-GFP
expression plasmid three days prior to experimentation.  Individual cells are
shown prior to (A, C) and 30 min after (B, D) the addition of the contractile
agents to the media.  Large arrows indicate the designated x-axis parallel to
the majority of $-actin stress cables.  Small arrows show cell debris
resulting from the forceful constriction of the cell.   Micrographs represent
the results from 22 experiments in which a total of 74 and 67 cells were
examined throughout the interval of contraction induced by PDB and A23187,
respectively.  Original magnification at 400X, scale bar (B) indicates 50
microns.
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Figure 2 The magnitude of decrease in cell length in the x-axis (hatched bar) parallel
to the system of actin stress cables and the perpendicular y-axis (solid bar)
in A7r5 cells at 30 minutes after the addition of phorbol 12,13 dibutyrate
(PDB) or the calcium ionophore A23187.  Data are calculated as the percent
of the resting cell length prior to stimulation.  Bars represent the average ±
SEM of results from 9 experiments in which a total of 74 and 67 cells were
studied throughout the interval of contraction induced by PDB and A23187,
respectively.  An (*) or (+) indicates a significant difference from the
unstimulated control value or between corresponding PDB and A23187
values, respectively (P <0.05). 
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Figure 3 The contraction of an A7r5 cell showing the shortening of individual $-
actin stress cables.  A) The cell prior to stimulation and at B) 5 minutes, C)
15 minutes, and D) 30 minutes after the addition of 10-8 M PDB to the
medium.  The cell was transfected with a $-actin-GFP expression plasmid
three days prior to experimentation.  The large arrow indicates the x-axis of
cell constriction while the small arrow points to an individual cable which
can be seen to shorten and appears to increase in diameter during cell
constriction.  Original magnification at 400X, scale bar (D) indicates 50
microns.
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Figure 4 The effect of cytochalasin B on the actin cytomatrix of unstimulated and
phorbol 12,13 dibutyrate (PDB)-stimulated A7r5 cells.  Control cells were
untreated (A) or stimulated by the addition of 10-8 PDB for 10 minutes (D)
prior to staining with TRITC-labeled phalloidin.  Cytochalasin B (0.1
µg/ml) was added to the medium of unstimulated cells for 10 minutes (B)
or 20 minutes (C) prior to fixing the cells for staining.  Stimulated cells
were incubated in the presence of PDB for 10 minutes and the cytochalasin
B added for an additional 10 minutes (E) or 20 minutes (F).  The
micrographs are representative of images collected in 4 individual
experiments in which a total of 425 cells were examined.  Original
magnification at 600X, scale bar (F) indicates 50 microns.
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Figure 5 The effect of cytochalasin-induced dissolution of the actin cytomatrix on
cell length in the precontracted A7r5 cell.  Cells were contracted by 10-8 M
PDB 30 minutes prior to the addition of 0.1 µg/ml cytochalasin B to the
media for up to 40 minutes.  Images are from a single cell transfected with
a $-actin-GFP expression plasmid three days prior to experimentation.  The
results show that within 10 minutes the cell began to elongate in the x-axis
(arrow) parallel to the visible $-actin stress cables.  Micrographs are
representative of images collected in 3 separate experiments in which 8
cells were evaluated.  Original magnification at 600X.
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Fig
ure 6 A comparison of unstimulated A7r5 cells (A, B) to cells stimulated with phorbol
12,13 dibutyrate (PDB) for 30 minutes (A’, B’) and then stained with TRITC-
labeled phalloidin to demonstrate the preservation of an extensive system of actin
stress cables and the formation of peripheral actin dense structures in the
stimulated cells. Due to the limited dynamic range of the imaging system, the
fluorescent signal is saturated when the image is presented at sufficient brightness
to display the peripheral bodies.  Micrographs were taken from a series of 8
separate experiments in which a total of 263 control and 280 PDB-stimulated cells
were evaluated.  Original magnification at 600X, scale bar (A’) indicates 50
microns.
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Figure 7 A comparison of unstimulated (A, B) and phorbol 12, 13 dibutyrate (PDB)
stimulated (A’B’) A7r5 cells stained with a monoclonal anti-$-actin clone
AC-15 primary antibody and an Alexa 488-labeled secondary antibody to
demonstrate the preservation of an extensive system of $-actin stress cables
and the lack of formation of peripheral dense structures in the stimulated
cells.  Micrographs were taken from a series of 3 separate experiments in
which a total of 94 control and 130 PDB-stimulated cells were evaluated. 
Original magnification at 600X, scale bar indicates 50 microns.
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Figure 8 A comparison of the "-actin cytomatrix in unstimulated A7r5 cells and
those treated with phorbol 12,13 dibutyrate (PDB) for 10 minutes (B, B’)
and 30 minutes (C, C’).  Cells were stained with a monoclonal anti-"-
smooth muscle actin clone 1A4 FITC-labeled antibody.  The results show
the loss of "-actin stress cables and formation of peripheral dense structures
in PDB-treated cells.  Micrographs are representative of images collected in
6 separate experiments in which a total of 432 PDB-stimulated cells were
evaluated.  An average of 80 ± 3% of cells showed significant loss of "-
actin cables and formation of peripheral dense structures.  Original
magnification at 600X, scale bar (C’) indicates 50 microns.
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Figure 9 Micrographs at magnification 600X (A, B) and 900X (A’, B’) showing the
association of "-actin peripheral dense structures with remnant "-actin
stress cables (arrow) (A, A’) and the aster-like formation of these structures
with associated "-actin filaments (B, B’).  Cells were incubated with 10-8 M
phorbol 12,13 dibutyrate for 30 minutes and then stained with a
monoclonal anti-"-smooth muscle actin clone 1A4 FITC-labeled antibody. 
Micrographs are exemplary examples of images collected in 6 separate
experiments.  Scale bars (B, B’) indicate 50 microns.
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Figure 10 A Z-plane series of sections taken in 4.0 micron increments from the cell
base (A) toward the cell apex (D) showing that peripheral dense structures
extend vertically as rod-or column-like bodies in the phorbol 12,13
dibutyrate (PDB)-treated cell.  Cells were incubated with 10-8 M PDB for
30 minutes and then stained with a monoclonal anti-"-smooth muscle actin
clone 1A4 FITC-labeled antibody.  Micrographs are representative of
results obtained in 2 experiments in which 60 cells were evaluated. 
Original magnification at 600X, scale bar (D) indicates 50 microns.
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Figure 11 Control experiments comparing "-actin remodeling in unstimulated cells
(Control; A, E); cells treated with 10-8 M phorbol 12,13 dibutyrate (PDB;
B, F); cell treated with the inactive phorbol ester, 4"-phorbol 12,13-
didecanoate (4" PDD; C, G); and cells treated with norepinephrine which
was shown to not stimulate constriction of A7r5 cells (NE; D, H).  Cells
were incubated with the indicated agents for 30 minutes and then stained
with a monoclonal anti-"-actin smooth muscle actin clone 1A4 FITC-
labeled antibody.  Micrographs are representative of results obtained in 3
experiments in which an average of 90 cells were evaluated for each
treatment group.  Original magnification at 600X, scale bar (H) indicates 50
microns.
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Figure 12 A comparison of the distribution of "-actinin in unstimulated cells and cells
stimulated to constrict by the addition of phorbol 12,13 dibutyrate (PDB) to
medium for 10 minutes or 30 minutes.  Cells were stained with a Anti-"-
Actinin primary antibody followed by the addition of an Alexa 488-labeled
secondary antibody.  The results show that the highly granular filamentous
organization of "-actinin in unstimulated cells undergoes remodeling to
form intensely fluorescing peripheral bodies in PDB-stimulated cells. 
Micrographs are representative of images obtained in 4 separate
experiments in which a total of 168 cells were studied.  An average of 82 ±
4% of PDB-treated cells showed "-actinin peripheral bodies.  Original
magnification at 600X, scale bar (30 minutes) indicates 50 microns.
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Figure 13 Dual immunostaining for "-actin and "-actinin in unstimulated (control)
and phorbol 12,13 dibutyrate-treated (PDB) A7r5 cells.  Yellow color
indicates colocalization of the two proteins.  Cells were stained for "-actin
using a monoclonal anti-"-smooth muscle actin clone 1A4 FITC-labeled
antibody.  "-Actinin was visualized using a monoclonal Anti-"-Actinin
primary antibody followed by an Alexa 594-labeled secondary antibody. 
Micrographs are representative of images obtained in 4 experiments in
which a total of 44 cells were evaluated.  Original magnification at 600X,
bar scale indicates 50 microns.
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Discussion
There are four isoforms of actin that have been identified in mammalian and avian smooth
muscle: "- and (-smooth muscle and $- and (- nonmuscle actin.  The $-actin isoform is
expressed in all smooth tissues examined thus far; whereas, the expression of the
remaining isoforms is tissue specific (Hartshorne, 1987).  For example, (-actin is found at
high concentration primarily in visceral smooth muscle (Hartshorne, 1987;
Vanderkerckhove and Weber, 1981; North et al., 1994) while "-actin is highly expressed
in vascular smooth muscle (Fatigati and Murphy, 1984; Hartshorne, 1987).  Despite the
fact that these different isoforms exhibit 95% homology in their amino acid sequence
(Pollard and Cooper, 1986), there is evidence to suggest that they are segregated into
separate functional domains (Rasmussen et al., 1987).  Small and coworkers (Small, 1986;
Draeger et al., 1990; North et al., 1994; Small, 1995) first described the separation of actin
filaments into “cytoskeletal” and “contractile” domains.  Cytoskeletal $-actin filaments
were observed to colocalize with cell cytoplasmic dense bodies, membrane dense plaques,
the intermediate filament component desmin, and the actin crosslinking protein filamin. 
By comparison, contractile filaments containing "- or (-actin are thought to be excluded
from the cytoskeletal domain and are found in association with myosin filaments.
The diacylglycerol analogue, PDB induced a robust, slowly developed cellular constriction
consistently observed in 85% or more of treated cells.  In the 30 minute interval following
PDB addition, cellular constriction was acentric, with greater shortening along the axis
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described by the densely packed, parallel array of actin stress cables extending across the
cell body (Figs. 1, 2, 3).  Nevertheless, there was significant constriction along the cell
periphery indicating a capability for force development in multiple axes.  During the
interval of constriction, the actin cytomatrix was observed to undergo extensive and highly
organized forms of remodeling.  Moreover, the $-actin and "-actin components could be
identified as functionally separate entities on the basis of their remodeling characteristics. 
Through use of cells expressing $-actin-GFP fusion protein, it was determined that this
isoform is incorporated into stress cables aligned in parallel with the principal axis of
constriction and that the $-actin cables shorten throughout the interval of cell constriction
(Fig. 3).  The localized effect of cytochalasin (Fig. 4) suggests that the length of individual
cables could be modified by polymerization/depolymerization and crosslinking of
filaments at the cell center.  The observation that cytochalasin-induced dissolution of
stress cables resulted in an elongation in the x-axis of precontracted cells (Fig. 5) further
suggests that the $-actin cables play an important role in maintaining the cell in the
contracted configuration in the x-axis.
Staining cells with phalloidin verified the preservation of the extensive system of actin
cables in PDB-stimulated cells (Fig. 6) previously noted in the $-actin-GFP studies.  In
addition, many of the phalloidin-stained cells showed evidence for the formation of
discrete peripheral structures not observed in experiments employing $-actin-GFP
expressing cells nor in cells stained with anti-$-actin antibody (Fig. 7).  These structures
were subsequently determined to result from the remodeling of "-actin (Fig. 8). 
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Immunostaining for "-actin revealed that, similar to $-actin, the " isoform was
incorporated into densely packed stress cables in unstimulated cells.  Stimulation of cell
constriction by PDB; however, caused a remarkable disassembly/reassembly of "-actin
resulting in the loss of most of the "-actin stress cables and formation of intensely
fluorescing rod-like bodies located at the cell periphery (Figs. 8, 9) and extending
vertically from the cell base (Fig. 10).  These peripheral dense structures showed strong
colocalization with "-actinin (Figs. 12, 13) suggesting they are analogous to cytoplasmic
dense bodies which anchor oppositely polarized actin filaments of the contractile
apparatus (Bond and Somlyo, 1982) in differentiated smooth muscle cells.  Consistent
with this idea, the peripheral dense structures were associated with remaining "-actin
filaments and appeared as focal points from which clusters of randomly oriented filaments
originated.  Furthermore, the peripheral ring of "-actin/"-actinin dense structures with
associated "-actin filaments formed within the first 10 minutes after PDB addition, during
the interval cells first begin to constrict.  The rapidity of remodeling of the "-actin domain
to this specific configuration concurrent with the onset of cell constriction may suggest an
active role in force development in PDB-induced contraction.
In the present study, we investigated changes in the actin cytomatrix of A7r5 cells during
PDB-induced contraction.  The A7r5 clonal smooth muscle cell line was derived from
embryonic rat aorta (Kimes and Brandt, 1976) and has been recently demonstrated to
exhibit an adult smooth muscle phenotype (Firulli et al., 1998).  These cells show
expression and promoter activity of several highly restricted smooth muscle cell markers
including: smooth muscle myosin heavy chain, "-actin, calponin (Firulli et al., 1998) and
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exhibit a high level of expression of SM22 alpha mRNA (Solway et al., 1995) which is
found exclusively in smooth muscle tissues and is considered one of the earliest markers
of differentiated smooth muscle.  A7r5 smooth muscle cells exhibit an inability to
proliferate in serum-free media and the absence of PDGF-$ mRNA (Firulli et al., 1998). 
They retain their responsiveness to the vasoactive agent arginine vasopressin (Byron,
1996) and their ability to contract in culture.  Nakajima et al. (1993) have utilized the
polydimethyl siloxane substrate “skin” method (Murray et al., 1990) to demonstrate the
development of contractile force by A7r5 cells in response to either high K+ or phorbol
esters.  They concluded that the contractile response to phorbol ester occurred by two
distinct mechanisms, one dependent and one independent of increased intracellular
calcium.  In our hands, A7r5 cells showed a strong contractile response to the calcium
ionophore A23187 and PDB but were not responsive to either angiotensin II or
norepinephrine.  This verifies the observation of a functionally intact contractile apparatus
while suggesting that some component of the receptor/transduction pathway of the ligand-
activated contractile response was absent in A7r5 cells.  Hence, many indicators suggest
that A7r5 cells represent a suitable model for the study of contractile function in vascular
smooth muscle.  It must be emphasized; however, that the actin cytomatrix of these cells
show many similarities to fibroblasts much like other smooth cell types which revert to a
less differentiated phenotype in culture (Chamley-Campbell et al., 1979).  In particular, we
note that "-actinin is not localized into discreet cytoplasmic dense bodies as seen in highly
differentiated smooth muscle cells.  Therefore, it is unlikely that present results can be
applied directly to contractile phenomenon in highly differentiated smooth muscle. 
Nevertheless, the results may provide some initial insight into the potential for actin
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remodeling relevant to contractile activity.
In summary, A7r5, smooth muscle cells retain the ability to undergo robust cellular
constriction to phorbol 12,13 dibutyrate.  Prior to stimulation both the "- and $-actin
domains of these cells are found primarily in large stress cables than extend the length of
the cell body.  Upon stimulation both domains undergo characteristic remodeling activity. 
$-Actin is retained in stress cables which shorten during the interval of cell constriction. 
Cytochalasin-induced dissolution of these stress cables in precontracted cells results in cell
elongation in the axis parallel to the system of stress cables leading us to speculate that
these structures serve to hold the cell in the contracted configuration.  By comparison, "-
actin stress cables disassemble and reform in association with "-actinin into column-like
structures which ring the cell periphery and appear to be associated with remaining "-actin
filament structure.  Because of the temporal relationship between the completion of
remodeling of the "-actin domain and the onset of observable cell constriction, we further
speculate that this specific configuration functions in active force development.  One
explanation is that the remodeling of the "-actin contractile domain increases mechanical
advantage or provides a structural arrangement allowing force development in multiple
axes.  Because there was no evidence of significant compression of "-actin stress cables
and filaments between 10 and 30 minutes after PDB addition (Fig. 8), the results further
suggest that these elements continued to remodel during the interval of cell constriction,
supporting the contention that remodeling of the contractile domain could modulate
optimal actin/myosin interaction and mechanical advantage of the system throughout the
interval of contraction.  Although not studied in the present investigation, the results
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further imply significant myosin redistribution in association with "-actin remodeling. 
The results demonstrate that the actin cytomatrix undergoes extensive and highly
organized remodeling which may play an important role in the contractile response to PDB
in A7r5 cells.  The present finding may provide initial insight into the extent and
characteristics of actin remodeling in contracting cells that do not have a well-defined
sarcomere.
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Chapter 3.  Myosin Remodeling in the Contracting
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A7r5 Smooth Muscle Cell
A manuscript submitted to Acta. Physiol. Scand.
M. E. Fultz and G. L. Wright
Abstract
Using confocal microscopy and standard immunohistochemical techniques, changes in the
structure of "-actin and $-actin as well as the distribution of myosin II were studied in the
contracting A7r5 smooth muscle cell.  Prior to stimulation, each of the three proteins were
incorporated into filamentous structures extending the length of the cell body.  At thirty
minutes after stimulation by phorbol 12, 13 dibutyrate (PDBu), the system of densely
packed $-actin fibers was retained.  By comparison, "-actin and myosin were observed to
undergo significant remodeling, characterized by loss in fiber structure and the formation
of brightly fluorescing peripheral bodies.  Dual immunostaining for "-actin and myosin II
revealed strong co-localization of the two proteins prior to stimulation.  Following
stimulation, myosin II was observed to partially disassociate from "-actin structure
beginning at five to ten minutes after PDBu addition and continuing throughout the
interval of contraction.  The use of cytochalasin B to block actin polymerization or the
selective dissolution of "-actin cable structure by thapsigargin produced similar patterns of
change in "-actin structure and the localization of myosin.  The results support the 
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concept of myosin evanescence and potential for remodeling.  The results suggest that
myosin undergoes extensive relocalization in association with "-actin remodeling during
PDBu-mediated contraction in the A7r5 smooth muscle cell.
Introduction
Studies of airway smooth muscle indicate that abrupt changes in tissue length result in a
dynamic alteration in contractile properties (Pratusevich et al., 1995; Wang et al., 2000). 
Immediately following the length change, ability to develop force is decreased.  However,
if the tissue is held at the new length it recovers the ability to generate force over an
interval of minutes.  It is proposed that the “adaptation” of smooth muscle to length
changes is due to the remodeling of myosin thick filaments to increase the length of
individual filaments and/or the number of contractile units in series (Ford et al., 1994;
Pratusevich et al., 1995).  The series-to-parallel transition in the myosin thick filament
lattice invoked by the concept of myosin remodeling (Seow et al., 2000) could explain
potentiation of isometric force and the inverse relationship between force and velocity of
isotonic shortening.
Early work (Kelly and Rice, 1968; Schoenberg, 1969) suggested a potential physiological
transience of myosin filamentous structure based on variable results obtained by different
preparative methods for tissue ultrastructure studies.  However, the bulk of subsequent
work provided little evidence of significant change in myosin thick filament density in
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contracted smooth muscle (Somlyo and Somlyo, 1992; Horowitz et al., 1994).  One
possible explanation is that myosin remodeling does not occur in all smooth muscles. 
Several studies of rat anococcygeus muscle, using different experimental approaches have
indicated that myosin filaments increase in length or number during contraction
(Godfraind-De Becker and Gillis, 1988; Gillis et al., 1988; Wantanabe et al., 1993; Xu et
al., 1997).  By comparison, no structural evidence for changes in myosin were observed in
guinea pig taenia coli (Godfraind- De Becker, 1988; Xu et al., 1997).  In a recent report
Kuo et al. (2001) have utilized conventional electromicroscopy to compare myosin
filament density at different intervals in the recovery of force generation in porcine airway
smooth muscle subjected to length oscillation.  Their results suggest that the initial loss in
force generating capacity is correlated with myosin depolymerization and approximate
27% decrease in thick filament density.  Subsequently, contractile force and myosin
filament density returned to preoscillation values suggesting a causal link between the two
parameters.
The finding of myosin lability and remodeling in anococcygeus and airway smooth muscle
but not taenia coli opens the question of how broadly this concept applies to different
smooth muscle types.  As pointed out by Xu et al. (1997), smooth muscles that do not
show assembly of myosin on activation may be influenced by additional factors that alter
the critical concentration for myosin assembly or act to stabilize filament structure. 
Alternatively, the characteristics of myosin remodeling could vary between cell types
reflecting subtle differences in contractile function or responsiveness to different stimuli. 
In the present study, we investigated the remodeling of myosin in the contracting A7r5
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smooth muscle cell using standard immunohistochemical techniques and confocal
microscopy.  The results confirm previous observations that "-actin undergoes extensive
remodeling during PDBu-induced contraction.  The results further suggest that myosin is
closely associated with  "-actin during the interval of contraction.
Materials and Methods
Cell Culture.  A7r5 smooth muscle cells were obtained from American Type Culture
Collection (Manassas, VA) and cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum, 100 units/ml penicillin G, and 100
µg/ml streptomyocin sulfate.  Cells were plated onto 75 mm2 culture flasks and grown to
approximately 85% confluence.  Cultures were maintained at 37°C in a humidified
atmosphere of 5% CO2 in air.  The medium was changed every two days and the cells were
passaged at least once a week.  Cells were detached from culture flasks by addition of a
trypsin/EDTA solution in HBSS.
Confocal Microscopy.  In experiments employing cell immunostaining, A7r5 cells were
plated onto 22 mm by 22 mm #1 glass coverslips placed in six well culture plates and
returned to the incubator for a minimum of 24 h to allow for cell attachment and
spreading.  Cells were fixed and permeabilized by the addition of ice cold acetone for 1
min.  The cells were then washed multiple times (3X) with phosphate-buffered saline
(PBS) containing 0.5% TWEEN-20 (PBS-T); pH 7.5, and incubated for 10 min in
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blocking solution (5% nonfat dry milk in PBS-T).  Cells were stained for "-actin by
incubation in a 1:500 dilution of monoclonal anti-"-smooth muscle actin clone 1A4 FITC-
labeled antibody (Sigma Chemical Co., St. Louis, MO) for 30 min at room temperature. 
Cells were stained for $-actin by incubation in a 1:500 dilution of monoclonal anti-$-actin
clone AC-15 primary antibody (Sigma Chemcial Co.) for 30 min at room temperature
followed by incubation with an Alexa 488-labeled secondary antibody (Molecular Probes,
Eugene, OR).  Myosin was visualized using an anti-myosin smooth muscle heavy chain
(G-4): SC-6956 antibody (Sigma Chemical Co) followed by Alexa 488-labeled secondary
antibody (Molecular Probes).  In dual immunostaining experiments to study the co-
localization of "-actin and myosin, Alexa 594-labeled secondary antibody (Molecular
Probes, Eugene, OR) was substituted for Alexa 488-labeled antibody.  Stained cells were
visualized by mounting on a Nikon Diaphot Microscope and confocal microscopy was
performed with a BioRad Model 1024 Scanning System equipped with a krypton/argon
laser.  Micrographs were built by projecting serial Z-plane image acquisitions and were
analyzed using Lasersharp and Confocal Assistant Software (BioRad, Hercules, CA).
Cell Treatments.  Actin and myosin cytoskeletal reorganization was studied in A7r5 cells
contracted by the addition of 10-8M phorbol 12, 13 dibutyrate (PDBu) to the incubation
medium.  In order to ensure that the results were not due to a non-specific effect of PDBu,
control experiments were also conducted using the inactive 4"-phorbol 12, 13-didecanoate
(4" PDD) at concentrations ranging to 10-6M.  Potential effects of nonspecific binding
were examined in additional experiments in which cells were incubated with secondary
antibody in the absence of primary antibody or in which a 5X molar excess of purified
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myosin protein (Sigma Chemical Co., St. Louis, MO) was mixed with primary antibody
prior to incubation.  In ancillary experiments to examine the effect of disruption of the
actin cytoskeleton on myosin distribution, cells were treated with 0.1 µg/ml of
cytochalasin B prior to and following stimulation with PDBu.  Because it has been
observed that a sustained high level increase in intracellular calcium ion concentration
causes a selective dissolution of "-actin cable structure (Li et al., in preparation), a final
series of experiments was conducted to examine the effect of 10-5M thapsigargin on
myosin localization in the A7r5 cell.
Results
Previous work (Fultz et al., 2000) has demonstrated that PDBu induces a slowly developed
but robust contractile response in A7r5 smooth muscle cells.  In excess of 85% of cells
respond with visible cell shortening which is first observed at about 8 minutes and
continues over an interval of approximately 60 minutes to completion.  PDBu-induced cell
constriction was extremely robust with the resolution of individual actin fibers often lost
by 45 minutes.
Figure 1 shows a comparison of A7r5 cells immunostained for "-actin, $-actin, and
myosin II before stimulation and 30 minutes after the addition of PDBu.  Prior to
stimulation each of these proteins were present in filaments or cables which extended
across the cell body.  At 30 minutes after addition of 10-8M PDBu, cells stained for $-actin
showed an extensive system of densely packed cables similar in appearance to
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unstimulated control cells.  By comparison, "-actin and myosin were observed to have
undergone extensive reorganization characterized by the formation of brightly fluorescing
peripheral bodies and an apparent reduction in the number of fibers.
Figure 2 shows the time course of change in smooth muscle specific myosin II distribution
in contracting A7r5 cells.  The results indicate significant reorganization of myosin by 10
minutes.  Because there was no evidence of compression of remnant filaments during the
interval between 10 and 60 minutes, the results further suggest that the reorganization
continued throughout the period of contraction. 
Co-localization studies indicated that myosin II is associated with "-actin in unstimulated
and contracting A7r5 cells (Figs. 3-7).  However, the association is less complete during
the interval of contraction and active "-actin remodeling.  Unstimulated control cells
exhibit clear stress fiber resolution and strong co-localization of "-actin and myosin (Fig.
3).  Within 5 minutes after the addition of PDBu, the resolution of myosin stained fibers is
reduced although there is continued evidence of a high level of association between the
two proteins (Fig. 4).  The first indication of visible cell constriction (Fultz et al., 2000)
and active "-actin remodeling with initial formation of peripheral bodies (Fig. 5) may be
observed at about 10 minutes after PDBu.  At this time point, myosin staining was clearly
diffuse with evidence of strong co-localization at peripheral bodies but reduced association
of myosin with "-actin stress fibers.  This pattern of dispersed myosin staining with high
levels of co-localization at peripheral bodies was also noted at 30 minutes (Fig. 6)
suggesting incomplete myosin association with "-actin during the period of cell
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contraction and active cytoskeletal remodeling.  At 60 minutes after the addition of PDBu,
the majority of cells cease to contract or demonstrate only minor further constriction.  In
those cells in which individual cytoskeletal structure could be resolved, the results suggest
a high level of "-actin/myosin association at peripheral bodies and increased co-
localization at stress fibers compared to earlier time points during active remodeling (Fig.
7).
Control experiments indicated that the partial dissociation and relocalization of myosin
induced by PDBu did not occur in cells treated with inactive 4"-phorbol 12, 13-
didecanoate (4" PDD) (Fig. 8).  Other experiments in which cells were incubated with
secondary antibody in the absence of primary antibody or in which the primary antibody
was mixed with a 5X molar excess of purified myosin protein (data not shown) indicated
that nonspecific binding had no significant effect on results.
Cytochalasin B caused distinct change in the structural organization of "-actin.  The use of
cytochalasin B to block actin polymerization resulted in the loss of "-actin stress fiber
integrity in unstimulated cells and prevented remodeling formation of peripheral bodies in
cells stimulated with PDBu (Fig. 9).  Cytochalasin-treated control and PDBu-stimulated
cells stained for myosin showed changes in structural organization similar to "-actin (Fig.
10).
Li et al. (in press) have recently shown that sustained elevation of [Ca2+]i by thapsigargin
results in partial to complete depolymerization of "-actin but does not affect $-actin stress
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fibers.  Similar to their findings, thapsigargin caused a significant loss in "-actin stress
fibers (Fig. 11).  Thapsigargin-treated cells stained for myosin showed dissolution of fiber
structure similar to  "-actin (Fig. 12).
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Figure 1. A comparison of the "-actin, $-actin, and myosin cytomatrix in unstimulated
A7r5 cells (control) and cells stimulated by the addition of phorbol 12, 13
dibutyrate (PDBu) for 30 minutes.  "-Actin was visualized using monoclonal
anti-"-smooth muscle actin clone 1A4 FITC-labeled antibody.  $-Actin was
visualized by incubation with anti-$-actin clone AC-15 primary antibody
followed by Alexa 488-labeled secondary antibody.  Myosin was visualized
with anti-myosin smooth muscle heavy chain (G-4):SC-6956 antibody
followed by Alexa 488-labeled secondary antibody.  Micrographs are
representative of images collected in six separate experiments in which a total
of 620 PDBu-treated cells were evaluated.  In excess of 80% of cells stained for
"-actin and myosin showed loss of fibers and relocalization of fluorescence at
peripheral bodies after PDBu.  Evidence of peripheral bodies was observed in
less than 2% of cells stained for $-actin.  Original magnification 400X, scale
bar indicates 50 microns.
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Figure 2. The time course of change in myosin localization in the A7r5 cell at intervals
up to 60 minutes after stimulation by PDBu.  Myosin was visualized using an
anti-myosin smooth muscle heavy chain (G-4):SC-6956 antibody followed by
Alexa 488-labeled secondary antibody.  The results show an early loss of well-
defined cable structure at 5 minutes and the first indications of myosin
localization at peripheral bodies by 10 minutes.  Micrographs are representative
of images collected in four separate experiments in which approximately 400
cells were examined at each time point.  An average of 78 ± 5% of cells
showed evidence of significant loss of cable structure and formation of
peripheral bodies by 30 minutes after PDBu.  Original magnification at 400X,
scale bar indicates 50 microns.
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Figure 3. Dual immunostaining for "-actin and myosin in unstimulated A7r5 cells.  Cells
were stained for "-actin using a monoclonal anti-"-smooth muscle actin clone
1A4 FITC-labeled antibody.  Myosin was visualized using a monoclonal
myosin heavy chain primary antibody followed by an Alexa 594-labeled
secondary antibody.  Yellow color indicates co-localization of the two proteins. 
Magnification of upper panels at 400X with boxed areas shown in lower panels
at 784X.  Micrographs are representative of images obtained in 4 separate
experiments in which a total of 243 cells were evaluated.
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Figure 4. Dual immunostaining for "-actin and myosin in A7r5 at 5 minutes after
stimulation with PDBu.  Cells were stained for "-actin using a monclonal anti-
"-smooth muscle actin clone 1A4 FITC-labeled antibody.  Myosin was
visualized using a monoclonal myosin heavy chain primary antibody followed
by an Alexa 594-labeled secondary antibody.  Yellow color indicates co-
localization of the two proteins.  Magnification of upper panels at 400X with
boxed areas shown in lower panels at 784X.  The results show strong co-
localization of the two proteins.  Note, however, the diffuse character of
myosin staining which has become apparent in the central region of the cell. 
Micrographs are representative of images collected in 4 separate experiments in
which a total of 95 cells were evaluated.
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Figure 5. Dual immunostaining for "-actin and myosin in A7r5 cells at 10 minutes after
stimulation with PDBu.  At this time point cells may be visibly observed to
have shortened while many show evidence of initial formation of brightly
fluorescent peripheral bodies.  Cells were stained for "-actin using a
monoclonal anti-"-smooth muscle actin clone 1A4 FITC-labeled antibody. 
Myosin was visualized using a monoclonal myosin heavy chain primary
antibody followed by an Alexa 594-labeled secondary antibody.  Yellow color
indicates colocalization of the two proteins.  Magnification of upper panels at
400X with boxed areas shown in lower panels at 784X.  Although there is clear
evidence of "-actin/myosin at developing peripheral bodies the results indicate
that myosin association with "-actin cable structure is significantly reduced. 
Micrographs are representative of images collected in 4 separate experiments in
which 125 cells were evaluated.
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Figure 6. Dual immunostaining for "-actin and myosin in A7r5 cells at 30 minutes after
stimulation with PDBu.  At this time point, the majority of cells exhibit
extensive "-actin remodeling with evidence of reduced cable structure and the
appearance of numerous brightly fluorescing peripheral bodies.  Cells were
stained for "-actin using a monoclonal anti-smooth muscle actin clone 1A4
FITC-labeled antibody.  Myosin was visualized using a monoclonal myosin
heavy chain primary antibody followed by an Alexa 594-labeled secondary
antibody.  Yellow color indicates co-localization of the two proteins. 
Magnification of upper panels is at 400X with boxed areas shown in lower
panels at 784X.  The results show strong co-localization of "-actin and myosin
at peripheral bodies and significant association of myosin with remaining "-
actin cables.  However, myosin staining did indicate that a significant portion
of this protein was diffusely distributed in the cell.  Micrographs are
representative of images collected in 4 separate experiments in which 122 cells
were evaluated.  
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Figure 7. Dual immunostaining for "-actin and myosin in A7r5 cells at 60 minutes after
stimulation with PDBu.  Cells were stained for "-actin using a monoclonal
anti-"-smooth muscle actin clone 1A4 FITC-labeled antibody.  Myosin was
visualized using a myosin heavy chain primary antibody followed by an Alexa
594-labeled secondary antibody.  Yellow color indicates co-localization of the
two proteins.  Magnification of upper panels is at 400X with boxed areas
shown in lower panels at 784X.  The results indicate highly significant co-
localization of "-actin and myosin at peripheral bodies and remaining "-actin
cables.  Micrographs are exemplary examples of images obtained in 4 separate
experiments in which 165 cells were examined.
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Figure 8. Control experiments comparing myosin distribution in the A7r5 cell prior to
stimulation and at 30 minutes after addition of 10-8M phorbol 12, 13 dibutyrate
(PDBu) or the inactive 4-"-phorbol 12, 13 dideconate (4" PDD).  Original
magnification 400X, scale bar indicates 50 microns.
81
Figure 9. Confocal micrographs showing the effect of cytochalasin B on "-actin structure
in unstimulated A7r5 smooth muscle cells and cells activated by the addition of
10-8M phorbol 12, 13 dibutyrate (PDBu) for 30 minutes, "-Actin was
visualized using a FITC-labeled anti-"-smooth muscle antibody.  Cytochalasin
B (0.1 µg/ml) was added 10 minutes prior to the addition of PDBu. 
Micrographs are representative of images obtained in 3 separate experiments in
which at least 150 cells were evaluated for each treatment.  Original
magnification at 400X, scale bar indicates 50 microns.
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Figure 10.  Confocal micrographs showing the effect of cytochalasin B on the localization
of myosin in unstimulated A7r5 cells and cells activated by the addition of 10-
8M phorbol 12, 13 dibutyrate (PDBu) for 30 minutes.  Myosin was visualized
using an anti-myosin heavy chain primary antibody followed by an Alexa 488-
labeled secondary antibody.  Cytochalasin B (0.1 µg/ml) was added 10 minutes
prior to the addition of PDBu.  Micrographs are representative of images
obtained in 3 separate experiments in which at least 150 cells were evaluated
per treatment.  Original magnification at 400X, scale bar indicates 50 microns.
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Figure 11.  Micrographs showing the effect of incubation with 2 X 10-6M thapsigargin on
 "-actin structure in A7r5 smooth muscle cells.  "-Actin was visualized using a
FITC-labeled anti-"-smooth muscle antibody.  Micrographs are representative
of results from 6 separate experiments in which a total of 495 thapsigargin-
treated cells were evaluated.  It was judged that 88 ± 3% of cells showed partial
to complete dissolution of "-actin structure.  Original magnification at 400X,
scale bar indicates 50 microns.  Boxed portions of cells indicate areas shown at
800X in lower panels.
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Figure 12.  Micrographs showing the effect of incubation with 2 X 10-6M thapsigargin on
the localization of myosin in A7r5 smooth muscle cells.  Myosin was
visualized using an anti-myosin heavy chain primary antibody followed by an
Alexa 488-labeled secondary antibody.  Micrographs are representative of
results from 4 separate experiments in which 405 thapsigargin-treated cells
were evaluated.  It was judged that 83 ± 5% of treated cells exhibited partial to
complete loss of filamentous structure.  Original magnification at 400X, scale
bar indicates 50 microns.  Boxed portions of cells indicate area chosen for
magnification at 800X in lower panels.
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Discussion
The results support earlier observations (Fultz et al., 2000) that "-actin and $-actin cellular
structures undergo distinctly different modes of remodeling during phorbol ester-induced
contraction of A7r5 smooth muscle cells (Fig. 1).  They showed that after activation, $-
actin remained incorporated into stress fibers which shortened during cell contraction
without evidence of individual fiber disassembly.  By comparison, "-actin stress fibers
underwent disassembly and reformed into numerous discrete peripheral bodies associated
with reduced numbers of randomly oriented "-actin fibers.  Because of the highly
structured nature of active actin remodeling and the temporal relationship of "-actin
remodeling to the onset of visible cell contraction, they proposed that the two modes of
remodeling reflected different functions.  It was suggested that $-actin fibers served to
hold the cell in the contracted configuration thus preserving tension gains;  whereas,
remodeling of "-actin was directly associated with force development.  The present
finding of "-actin/myosin association throughout the interval of active remodeling is
consistent with the proposed role of "-actin remodeling in force development.
Based on the diffuse character of myosin staining, the results suggest that myosin is
partially dissociated from actin during active "-actin remodeling (Figs. 5, 6).  It is unlikely
that these observations represent an artifact of sample preparation or imaging technique
because the dispersal of myosin in the cytosol was only observed in the interval following
PDBu and was not apparent in cells treated with inactive 4"PDD (Fig. 8).  The results
indicate significant  remodeling and relocalization of myosin but suggest that this activity
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may be permissive, depending on "-actin structural dynamics.  This conclusion is
consistent with the further observation that myosin localization closely follows distinctive
changes in "-actin structure produced by low concentrations of cytochalasin B (Fig. 9) or
incubation of cells with thapsigargin (Fig. 12).
The present findings support the concept of myosin evanescence (Ford et al., 1994) but
argue against increased thick filament density as a primary goal of contractile remodeling
(Kuo et al., 2001).  Instead, they suggest a highly coordinated remodeling of the "-
actin/myosin lattice consistent with the proposal of continued reorganization of the
contractile apparatus during contraction (Wright and Hurn, 1994; Battistella-Patterson et
al., 1997; Fultz et al., 2000) of the A7r5 cell.  It must be emphasized, however, that there
is presently no evidence to indicate that a common mechanism of contractile remodeling
occurs among cells lacking a well-defined sarcomere.  For example, based on controversy
surrounding myosin thick filament densities in contracted tissues, Kuo et al. (2001) have
suggested that remodeling of the contractile lattice differs between cell types or may be
absent in some cells.  Irrespective of differences between cell types, we consider it likely
that major differences will be observed in the contractile remodeling in isolated cells
versus studies with tissues.  Cells in vivo would be expected to experience some degree of
limitation in contractile shortening due to their preload and the constraining influences of
the extracellular matrix and cell/cell adhesion.  It has been reported that some types of
smooth muscle can decrease their length in vitro by as much as 75% (Gabella, 1984) and
isolated cells have been observed to contract into a spherical shape (Mamose and Gomi,
1977).  We recently reported a similar phenomenon in A7r5 cells, noting that within 45 to
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60 minutes after additions of phorbol ester the majority of cells constricted to a point that
the resolution of individual actin fibers was lost (Fultz et al., 2000).  This suggests that
contraction and cytoskeletal remodeling in the unloaded cell may continue unabated until
constrained by coalescence of the cytoskeleton.  Thus, contractile remodeling in the
isolated, unloaded cell may represent a greatly exaggerated response compared to that of
preloaded tissue.
Hence, it is uncertain to what extent findings in A7r5 cells are applicable to mechanisms
underlying the contractile properties of highly differentiated smooth muscle.  The A7r5
clonal smooth muscle cell line was originally derived from embryonic rat aorta (Kimes
and Brandt, 1976) and exhibits an adult smooth muscle phenotype (Firulli et al., 1998). 
These cells show expression and promoter activity of highly restricted smooth muscle cell
markers including: smooth muscle myosin heavy chain, "-actin, calponin (Firulli et al.,
1998) and exhibit a high level of expression of SM22 " mRNA (Solway et al., 1995)
which is expressed exclusively in smooth muscle and is considered one of the earliest
markers of differentiated smooth muscle.  A7r5 cells are unable to proliferate in serum-
free media and in the absence of PDGF-$ mRNA (Firuilli et al., 1998).  They retain
responsiveness to vasoactive arginine vasopressin (Byron, 1996) and the ability to contract
by both increased intracellular calcium-dependent and-independent mechanisms
(Nakajima et al., 1993; Fultz et al., 2000).  Therefore, there are many indicators to suggest
that A7r5 may serve as a model for the study of contractile function in smooth muscle. 
Nevertheless, the actin cytomatrix of these cells shows many structural similarities to
fibroblasts much like other smooth muscle cell types which revert to a less differentiated
88
phenotype in culture (Chamley-Campbell et al., 1979).  In particular, we note significant
gross structural similarity between the peripheral bodies of contracting A7r5 cells and
“aster-like assemblies” (Verkhovsky et al.1997) in fibroblasts contracted by treatment with
cytochalasin.  Verkhovsky et al. (1997) explained the formation of these structures as due
to actin/myosin interaction resulting in actin filament polarity sorting and formation of
radial arrays of actin filaments with barbed ends oriented toward clusters of myosin. 
These findings are consistent with a network arrangement of actin/myosin and could
explain nonsarcomeric tension development if dynamic uncoupling of actin filament
crosslinking and filament remodeling are presumed.
In summary, the use of confocal microscopy and standard immunohistochemical staining
techniques have enabled a relatively detailed evaluation of changes in the localization of
smooth muscle specific myosin II in A7r5 cells during PDBu-induced contraction.  The
results indicate that myosin undergoes dramatic reorganization in association with "-actin
but not $-actin structural remodeling.  The results are consistent with earlier conclusions
that the remodeling of "-actin is an important factor in force development by cells which
lack a highly structured sarcomere.
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Chapter 4.   Correlation of Force Development
with a-actin Remodeling in Smooth Muscle:
Effects of Specific Protein Kinase Inhibitors.
A manuscript prepared for submission
M.E. Fultz and G.L. Wright
Summary
Remodeling of "-actin and $-actin is markedly different in the contracting A7r5 cell (Fultz
et al., 2000) suggesting that the two isoforms may play different functional roles.  Based
on remodeling characteristics it was proposed that "-actin is involved in force
development while $-actin stress cables serve to hold tension in the cell.  In the present
study, we examined the effect of seven protein kinase inhibitors on the relationship
between force developed, tension maintenance, and "-actin remodeling.  Inhibition of
PKC (10-9M bisindolymaleimide I, -75%) and tyrosine kinase (2.5 x 10-6M genistein, -
62%) significantly decreased early force development but had little subsequent effect on
tension maintenance.  By comparison, inhibition of calmodulin kinase II (3.7 x 10-6M KN-
93) only moderately reduced force development (-32%) but significantly decreased tension
maintenance (-51%).  At concentrations expected to block both PKC and calmodulin
kinase II (7 x 10-7M), the ser/thr kinase inhibitor staurosporine significantly decreased both
force development (-70%) and tension maintenance (-74%) in rat aortic rings.  Each of the
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active kinase inhibitors reduced "-actin remodeling in A7r5 cells with regression analysis
indicating a significant r = 0.77, p < 0.01) relationship between force development and "-
actin reorganization.  By comparison, the correlation between tension maintenance and "-
actin remodeling (r = 0.50) was not statistically significant.  The results suggest that force
development and tension maintenance are regulated differently and support the proposal
that force development is linked to "-actin remodeling.
Introduction
The principal biochemical and biophysical pathway of smooth muscle contraction is
thought to be initiated in a manner similar to skeletal muscle.  Stimulation of smooth
muscle results in an elevation of intracellular calcium which then leads to activation of
calmodulin.  The calcium-calmodulin complex activates myosin light chain kinase which
results in the phosphorylation of Ser 19 on the myosin light chain.  Phosphorylation of the
myosin light chains results in myosin ATPase activity and subsequent myosin/actin
crossbridge formation and cycling occurs.  However, it has been shown that slow force
development, maintenance of tension (Driska et al., 1981) and velocity of shortening
(Merkel et al., 1990) are disassociated from myosin light chain phosphorylation and
myosin ATPase activity (Zhang and Moreland, 1994) in smooth muscle.  Also noteworthy,
it has been demonstrated that phorbol ester-induced contraction can occur in the absence
of a detectable increase of intracellular Ca2+ (Nakajima et al., 1993) or concomitant
increased myosin light chain phosphorylation (Singer and Baker, 1987).
A number of protein kinases not presently associated with the established smooth
94
muscle pathway of contraction have been shown to alter the contractile response.  It has
been shown that Protein Kinase C (PKC) is tonically activated in response to a variety of
contractile agonists (Haller et al., 1990; Singer et al., 1992); whereas, the inhibition or
down-regulation of this enzyme blocks or attenuates the contractile response to different
agonists (Merkel et al., 1991, Shimamoto et al., 1993, Wright and Hurn, 1994).  Also of
interest is the finding that the inhibition of tyrosine kinase (Di Salvo et al., 1993; Di Salvo
et al., 1994; Gokita et al., 1994; Sriuasta and St-Louis, 1997; Tolloczko et al., 2000;
Duarte et al., 1997) blocks contraction in smooth muscle to various agonists which has
been suggested to reflect an important role of this kinase in electromechanical coupling or
the direct activation of the contractile apparatus by Ca2+ in the cell (Di Salvo et al., 1993,
Di Salvo et al., 1994, Tolloczko et al., 2000, Gokida et al., 1994).  Finally, Rokolye and
Singer (2000) have shown that the inhibition of calmodulin kinase II (CAMK II) has
variable effects on early force development and tension maintenance depending on the
agonist used to activate contraction.  They concluded that KN-93, a calmodulin kinase II
inhibitor, may play a role in regulating maintained tension in activated smooth muscle and
that this inhibition could be abolished by activation of PKC.  
Recent interest has focused on the role of cytoskeletal organization on smooth
muscle contractile properties.  Wright and Hurn (1994) first demonstrated that the use of
cytochalasin to inhibit actin polymerization caused a selective blockade of the slow
tension increase in rat aortic smooth muscle.  They suggested that the slow tension
development by smooth muscle required a capability for dynamic remodeling of a portion
of the actin cytoskeleton during the interval of contraction.  Their conclusion has been
supported by recent studies showing that inhibition of actin polymerization by latrunculin-
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A depressed force development without affecting myosin light chain phosphorylation,
further suggesting that actin polymerization contributes directly to force development
(Mehta and Gunst, 1999).  Other work (Wright and Battistella-Patterson, 1998) has shown
that inhibition of actin polymerization blocks calcium-dependent stress relaxation in
vascular smooth muscle, suggesting that remodeling of the actin cytoskeleton may also
serve to decrease cellular tension following abrupt stretch.  Taken together, the results
suggest that the effects of inhibition of actin polymerization on the contractile and stress
relaxant properties of smooth muscle cannot be attributed to a simple loss in cytoskeletal
structure but more accurately reflects the inhibition of dynamic actin cytoskeletal
remodeling.
Battistella-Patterson et al. (1997) have proposed that actin remodeling could serve
to modulate the optimal positioning of actin and myosin filaments during the interval of
force development and hold the cell in the constricted configuration during tension
maintenance.  Recently Fultz et al. (2000) have defined the A7r5 smooth muscle cell line
as a model for actin remodeling in cells that lack a highly structured sarcomere.  They
showed that "-actin and $-actin undergo highly structured and distinctly different modes
of remodeling during contraction.  Their findings have provided support for the concept of
a direct role of actin remodeling in force development (Wright and Hurn, 1994; Battistella-
Patterson et al., 1997; Mehta and Gunst, 1999) and further suggest that $-actin stress
cables maintain contractile tension while "-actin remodeling is linked to force
development.
In the present study, we utilized various kinase inhibitors to demonstrate that
attenuated force development and tension maintenance may also alter the remodeling of
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the "-actin cytoskeleton.  Our results indicate a correlation between "-actin remodeling
and force development, further implicating the reorganization of the actin cytoskeleton as
an important component in smooth muscle contraction.
Materials and Methods
Animals.  Male, 12 week old Sprague Dawley rats were utilized in cell experiments
including aortic ring segment contractility.  All rats were housed in rooms maintained at
23 ± 2°C with a 12:12 hour light-dark cycle.  Animals were allowed unrestricted access to
Purina Rat Chow and tap water.
Contractility Measurements.  The evaluation of in vitro contractile response was
performed as previously described (Huang et al., 1988).  Rats were anesthetized with a
Ketamine-xylazine mixture (21.9 mg/kg) and the thoracic aorta was removed, placed into
warm Krebs buffer (118mM NaCl, 4.7mM KCl, 1.5mM CaCl2, 25mM NaHCO3, 1.1mM
MgCl, 1.2 mM KH2PO4 and 5.6mM glucose, pH 7.4), maintained at 37°C and aerated with
a 95% O2/5% CO2 mixture.  Tissues were cleaned of adherent tissue and cut into rings
approximately 0.3 cm in length.  Rings were denuded of endothelium and mounted on
stainless steel hooks under 1.0g of passive tension in glass organ baths containing KREBS
buffer maintained at 37°C and aerated with 95% O2 /15% CO2.  The tissues were allowed
to equilibrate for a minimum of 1 hour before undergoing a reference contraction to 80mM
K+.  After the reference contraction, the tissues were returned to baseline tension by
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rinsing with fresh buffer.  The tissues were then allowed to equilibrate for 30 minutes,
kinase inhibitor was then added for an additional 30 minutes and the tissue contracted by
addition of 10-8M phorbol 12, 13 dibutyrate (PDBu).  The force generated was recorded at
the plateau in tension (approximately 30 minutes) as a measure of early force development
(Fig. 1).  Force was again recorded at 90 minutes for comparison with the 30 minute value
as a measure of ability to maintain tension.  Isometric tension was recorded using a force-
displacement transducer (Grass FTD3) and a Grass Model 7D polygraph.
A total of seven protein kinase inhibitors were investigated: staurosporine, a general
serine/threonine kinase inhibitor; bisindolymaleimide II, highly specific for protein kinase
C(PKC); KN-93, highly specific for calmodulin kinase II (CAMKII); H-89, selective for
protein kinase A (PKA); ML-7, selective for myosin light chain kinase (MLCK); genistein,
a general tyrosine kinase inhibitor; and AG1478, a tyrosine kinase inhibitor selective for
epidermal growth factor receptor kinase (EGFR).  To ensure effective inhibition, each
compound was added at a final concentration of 10X its reported IC50 or K4 value (Table
1).  Because it was reasoned that inhibition of contractile responsiveness by different
kinase pathways might have variable effects on "-actin remodeling, a single inhibitor
(genistein) was selected for study at 0.1X, 1.0X and 10.0X of its IC50 concentration.
Cell Culture.  A7r5 cells, derived from embryonic rat aorta, expressing smooth muscle
markers (Firulli et al., 1998), and maintaining the ability to contract in response to phorbol
esters (Fultz et al., 2000; Nakajima et al., 1993), were obtained from American Type
Culture Collection (Manassas, VA).  Cells were cultured on 75 mm2 flasks and grown to
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approximately 85% confluence at a maintained temperature of 37°C in a humidified
atmosphere of 5% CO2 in air.  The cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) that was supplemented with 10% fetal bovine serum, 100 units/ml
penicillin G, and 100 µg/ml streptomycin.  Media was changed every other day and cells
were passaged at least once per week.  Passaging was accomplished by addition of a
trypsin/EDTA solution in HBSS to the culture flask and subsequent collection of the
detached cells.
Confocal Microscopy.  In experiments where immunostaining was performed, A7r5 cells
were seeded onto glass coverslips, placed in 6 well culture plates and returned to the
incubator for a minimum of 24 hours to allow for cell attachment and spreading.  After
experimental treatment, cells were fixed and permeabilized by the addition of ice cold
acetone for 1 minute.  The cells were washed several times in phosphate-buffered saline
(PBS) containing 0.5% TWEEN-20 (PBS-T) pH 7.5 followed by incubation with a
blocking solution containing 5% nonfat dry milk in PBS-T for 10 minutes.  "-Actin
staining was accomplished by the incubation of the cells with a 1:500 dilution of
monoclonal-"-smooth-muscle actin, clone 1A4, FITC-labeled antibody (Sigma Chemical
Co., St. Louis, MO) for 30 minutes at room temperature.  Cells stained for $-actin were
incubated in a 1:500 dilution of monoclonal anti-$-actin clone AC-15 primary antibody
(Sigma) for 30 minutes followed by incubation with an Alexa 488 labeled secondary
antibody (Molecular Probes, Eugene, OR).  Cells were visualized by mounting on a Nikon
Diaphot Microscope and confocal microscopy performed with a BioRad Model 1020
scanning system with a Krypton/Argon laser.  Micrographs were constructed by projection
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of Z-plane acquisitions and analyzed by Lasersharp and Confocal Assistant software
(BioRad, Hercules, CA).
Cell Treatments.  The effect of various kinase inhibitors on actin remodeling was studied
in A7r5 cells by the addition of either 0.1X, 1.0X or 10.0X the reported IC50, or the Ki of
the particular kinase of interest (Table 1) at 30 minutes prior to cell stimulation.  Control
cells received vehicle only.  The actin cytoskeletal reorganization and cell contraction was
then stimulated by the addition of phorbol 12, 13 dibutyrate (PDB) to the incubation media
at a final concentration of 10-8M.  Cells were typically  allowed to undergo phorbol-
induced contraction  for 15 minutes before fixation and immunohistochemistry.
Data Analysis and Statistics.  Each experiment evaluating "-actin remodeling was
performed a minimum of 3 times with a total of approximately 300 cells evaluated per
experiment.  Cells were scored as having undergone "-actin remodeling if there was a
significant loss of stress fibers and the presence of "-actin peripheral dense bodies.  Cells
were evaluated independently by 2 viewers and the counts averaged.  Analysis of data was
performed by one factor ANOVA followed by Tukey test utilizing Sigma Plot and Sigma
Stat Software (SPSS, Chicago, IL).  Differences were considered significant if p < 0.05. 
Data are presented as mean ± SEM.
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Results
Contractile effects of protein kinase inhibitors.  Individual protein kinase inhibitors
affected early force development and tension maintenance by aortic rings in a variable
fashion (Table 2, Fig. 1).  PDB caused robust force development with maximum tension at
about 158% of that obtained in reference contractions to high K+ (Table 2).  Of seven
protein kinase inhibitors investigated staurosporine (ser/thr, -70%), bisindolymaleimide I
(PKC, -75%), and genistein (tyrosine kinase, -98%) significantly reduced early force
development.  The CAMKII inhibitor KN-93 caused a moderate (-31%) reduction in force
development compared to controls but the difference was not statistically significant.  The
remaining inhibitors of PKA, MLCK, and the highly specific tyrosine kinase EGFR had no
detectable effect on early force development.
A comparison of control values (Table 2) from experiments with aortic rings indicates that
the force generated in response to PDBu was well maintained, averaging less than a 7%
decrease in tension between 30 and 90 minutes.  Of the two kinase inhibitors shown to
partially block early force development, staurosporine caused a significant (-75%) loss in
tension maintenance between 30 and 90 minutes; whereas, the specific PKC inhibitor
bisindolymaleimide I had no effect on this parameter.  Similarly, it was observed that low
concentrations of the tyrosine kinase inhibitor genistein which partially blocked early force
development had no effect on subsequent maintenance of tension (Table 3).  Interestingly,
the CAMKII inhibitor KN-93, which only moderately reduced early force development,
caused a significant (-52%) loss in ability to maintain tension (Table 2).  The remaining
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protein kinase inhibitors; H-89, ML-7, and AG1478 had no detectable effect on tissue
tension maintenance (Table 2).
Effects of protein kinase inhibitors on "-actin remodeling in A7r5 cells.  Figure 2
shows PDB-induced remodeling of "-actin in the A7r5 cells and the appearance of these
cells treated with protein kinase inhibitor shown to block early force development in rat
aortic smooth muscle.  Prior to stimulation, "-actin forms stress cables which span the cell
body (Fig. 2A).  Within 8 to10 minutes after the addition of phorbol, the "-actin stress
cables disassemble and reform into brightly fluorescing peripheral bodies with a reduced
number of associated filaments (Fig. 2B).  By comparison, cells treated with kinase
inhibitors (Fig. 2 C-F) did not show loss of cable structure or formation of peripheral
bodies, providing an unambiguous indicator of lack of "-actin remodeling.
Each of the protein kinase inhibitors shown to alter smooth muscle contractile
responsiveness (staurosporine, -69.8%; bisindolymaleimide I, -95.7%; KN-93, -92.2%;
genistein, -92.2%) significantly reduced the percent of A7r5 cells undergoing "-actin
remodeling in response to PDB (Table 3, 4).  Regression analysis of percentage of cells
showing remodeling against the percentage of early force development in tissues treated
with the different kinase inhibitors indicated a significant correlation (r = 0.77) between
the two parameters (Fig. 3).  A similar analysis of results, from studies of the individual
kinase inhibitor genistein, further indicated a high level of correlation (r = 0.95) between
force development and "-actin remodeling (Fig. 4).  In contrast, regression analysis of the
reduction in tension between 30 and 90 minutes in aortic rings and the percentage of cells
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showing "-actin remodeling indicated no significant relationship (r = -0.50, NS) between
these parameters (Fig. 5).
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Figure 1 Tracings from contractile response of rat aortic rings in response to 10-8M
PDB, showing the effects of kinase inhibitors (broken line) on isometric
force generation and maintenance of tension compared to control (solid
line) tissues. The inhibitors shown are (A) staurosporine, (B)
bisindolymaleimide I, (C) KN-93, (D) ML-7, (E) H-89, and (F) genistein. 
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Figure 2 The effect of (C) genistein, (D) staurosporine, (E) KN-93, and (F)
bisindolymaleimide I on the phorbol induced remodeling of "-actin. 
Control cells were given vehicle (A) or stimulated by the addition of 10-8M
PDB for 10 minutes (B).  Inhibitors were added (10X IC50, 30 minutes)
before stimulation by PDB.   Inhibitor treated cells did not undergo the
characteristic "-actin remodeling and the formation of peripheral dense
bodies observed in control cells.  Original magnification at 400X, scale bar
(F) indicates 50 microns.
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Figure 3 Regression analysis of maximal tension development in rat aortic rings and
percent control of A7r5 cells showing "-actin remodeling after treatment
with different kinase inhibitors.  Data are calculated as percent of control
values from untreated tissues or cells in each experiment.  Each point
represents the average of 3 experiments with a single compound studied at
10X its IC50 or its Ki value.
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Figure 4 Regression analysis of maximum tension developed in rat aortic rings and
percent of A7r5 cells showing "-actin remodeling after treatment with the
protein tyrosine kinase inhibitor genistein at 0, 0.1X, 1X, and 10X its IC50
concentration.  Data are calculated as percent of the control value.
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Figure 5 Regression analysis of deterioration in force maintenance in rat aortic rings
and percent of A7r5 cells showing "-actin remodeling.  After treatment
with different kinase inhibitors "-actin remodeling is calculated as %
controls values from untreated cells.  Deterioration in force is calculated as
the change in maximum tension and tension maintenance at 90 minutes
after PDB stimulation.  The data point for genistein was dropped due to the
total inhibition of contractile response.  Each point represents the mean of 3
experiments with a single compound at its 10X concentration.
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Table 1. The IC50, Ki concentration of different kinase inhibitors employed in
present studies.
Inhibitor (Target Kinase) IC50 , Ki
Staurosporine (Ser/Thr) 7.0 x 10-8 M
Bisindolymaleimide I (PKC) 1.0 x 10-10 M
KN-93 (CAM II) 3.7 x 10-7 M
H-89 (PKA) 5.0 x 10-10 M
ML-7 (MLCK) 3.0 x 10-11 M
Genistein (Tyrosine Kinase) 2.5 x 10-6 M
AG1478 (EGFR) 3.0 x 10-9 M
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Table 2. Effects of different protein kinase inhibitors on early force development (30
minutes) and tension maintenance (90 minutes) in control aortic rings and
rings incubated with different protein kinase inhibitors (10X IC50) for 30
minutes prior to contraction with 10-6M PDBu.
30 Minute 90 Minute
Inhibitor (Target) Control Inhibitor Control Inhibitor
Staurosporine
(Ser/Thr)
141 ± 20    43 ± 12* 134 ± 23   11 ± 4†
Bisindolymaleimide I
(PKC)
163 ± 22    41 ± 18* 134 ± 37   35 ± 19
KN-93 (CAMK II) 158 ± 13 109 ± 16 149 ± 15    53 ± 15†
H-89 (PKA) 129 ± 13 131 ± 10 120 ± 15 104 ± 17
ML-7 (MLCK) 155 ± 11 136 ± 15 148 ± 11 117 ± 21
Genistein (Tyrosine
Kinase)
150 ± 18     3 ± 2* 139 ± 20   3 ± 2
AG1478 (EGFR) 209 ± 12 179 ± 29 198 ± 19 158 ± 36
Values are calculated as the percent of the reference contraction to 80 mM potassium.  An
asterisk (*) or cross (†) indicates a significant difference from the 30 minute control value and
between the values obtained for inhibitor treated tissues at 30 and 90 minutes, respectively, p <
0.05.
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Table 3. The effect of the tyrosine kinase inhibitor genistein on early force
development (30 minutes) and tension maintenance (90 minutes) in rat
aortic rings contracted with 10-8 PDB.  Genistein concentrations were tested
at 0.1X, 1X, and 10X of the published IC50 value.
Control 0.1X 1X 10X
Early Force
Development
(30 minutes) 150 ± 18 116 ± 19 57 ± 21*   3 ± 2*
Tension
Maintenance 139 ± 20 105 ± 20 44 ± 19 3 ± 2
(90 minutes) (7.4%) (9.5%) (22.9%) (0)
Values are calculated as percent of the reference contraction to 80 mM potassium.  An asterisk indicates a
significant difference in early force development, p < 0.05.  Values in parenthesis indicate % decline in
tension between 30 and 90 minutes.
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Table 4. Effect of several kinase inhibitors (10X IC50) on the number of cells
showing successful "-actin remodeling after PDB stimulation.  Data are
presented as percentage of values obtained for vehicle controls in each
experiment.
Inhibitor (Target Kinase) "-Actin Remodeling, %
Staurosporine (Ser/Thr)   30.2 ± 2.0*
Bisindolymaleimide I (PKC)     4.3 ± 1.6*
KN-93 (CAMK II)     6.6 ± 3.3*
H-89 (PKA)   97.5 ± 11.9
ML-7 (MLCK) 97.9 ± 6.3
Genestein (Tyrosine Kinase)     7.8 ± 3.1*
AG1478 (EDGFR) 77.0 ± 9.3
* Indicates significant difference from control, p < 0.05.
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Discussion
Battistella-Patterson et al. (1997) proposed that the broad length-tension relationship, slow
force development and the low energy cost of maintained tension in smooth muscle could
be explained by remodeling of the actin cytoskeleton to modulate optimal actin/myosin
overlap and to form a stable system of tension bearing elements to hold the cell in the
contracted configuration.  They modeled this concept in terms of asynchronous contraction
in which it was proposed that different portions of the actin cytoskeleton undergo
alternating active contraction, tension maintenance, and remodeling.  Subsequently, Fultz
et al. (2000) have shown "-actin and $-actin remodel differently in the contracting A7r5
cell.  Both actin isoforms are incorporated into stress cables in the unstimulated cell. 
Upon stimulation, $-actin cables shorten without evidence of disassembly or new cable
formation.  By comparison, "-actin cables were observed to undergo dramatic disassembly
and reform into a ring of column-like structures located at the cell periphery, in association
with randomly oriented "-actin cables and filaments.  Importantly, neither the $-actin or
"-actin components showed evidence of compression indicating that remodeling of the
system continued throughout the interval of cell contraction.  Based on these findings,
Fultz et al. (2000) concluded that their results supported the earlier proposal by Battistella-
Patterson et al. (1997) but suggested that $-actin remodeling served to hold tension,
whereas, "-actin remodeling was directly linked to active force development.  Present
findings confirm the work of others demonstrating that several classes of protein kinase
inhibitors may significantly attenuate the contractile response in vascular smooth muscle. 
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The results show further that specific inhibitors may selectively reduce early force
development or tension maintenance, suggesting the two activities may be differently
regulated.  Inhibition of PKC (bisindolymaleimide I) and tyrosine kinase (genistein) both
reduced early force development with little evidence of a subsequent effect on tension
maintenance (Table 2, 3).  By comparison, the inhibition of CAMKII only moderately
reduced force development but significantly decreased tension maintenance.  The
conclusion of separately determined force development and tension maintenance was
further strengthened by the observation that the ser/thr kinase inhibitor staurosporine,
which was expected to block both PKC and CAMKII at the concentration used,
significantly decreased both contractile parameters.  Finally, several of the kinase
inhibitors investigated showed no activity in reducing either force development or tissue
maintenance, suggesting the results were due to specific kinase inhibition.
Regression analysis indicated a significant correlation in the relationship between early
force development and "-actin remodeling among tissues and cells treated with different
kinase inhibitors (Fig. 3) and those treated with several concentrations of the individual
inhibitor, genistein (Fig. 4).  The finding that inhibition of three classes of kinase which
reduce contractile force also block "-actin remodeling may be suggesting that several
biochemical pathways regulate "-actin remodeling.  However, it is difficult to envision a
mechanism based solely on enzymatic regulation that would precisely modulate
cytoskeletal remodeling to accommodate the mechanical requirements of the cell.  In
studies of stress relaxation of activated smooth muscle, Wright and Battistella-Patterson
(1998) concluded that the isometric loss in tension was due to remodeling of the actin
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cytoskeleton and that the magnitude of relaxation was associated with the degree of strain
placed on the tension-bearing elements of the system.  Noteworthy from present results,
A7r5 cells treated with kinase inhibitors did not show compression or dissolution of "-
actin structure but were similar in appearance to unstimulated control cells.  This suggests
that direct biochemical regulation of "-actin remodeling may play a permissive role while
perturbations in mechanical strain are obligatory for initiation of reorganization in the
system.  Hence, the surprising level of correlation between force development and "-actin
remodeling among tissues and cells treated with different classes of kinase inhibitors may
reflect either a direct effect on actin remodeling or an indirect effect through attenuation of
initial force development and perturbation in the distribution of tension in the system.
Present findings indicate no significant relationship between "-actin remodeling and
tension maintenance.  Based on the observation that the addition of cytochalasin prior to
initiation of contraction blocked slow force development but had little effect in
precontracted tissue, Wright and Hurn (1994) concluded the results were consistent with
action against a semistable structure undergoing remodeling during tension development
with stabilization and cessation of remodeling at the plateau in tension.  It was
subsequently proposed that tension maintenance could be explained by the remodeling of
actin to a stable structure holding the cell in the constricted configuration (Battistella-
Patterson et al., 1997; Fultz et al, 2000).  Because of the marked effect of KN-93 on the
loss in tension maintenance in aortic rings, the results may be suggesting a role of
calmodulin kinase II in the stabilization of tension bearing actin filaments in PDBu
contracted cells.
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In summary, the inhibition of PKC and tyrosine kinase markedly reduced early force
development without affecting tissue maintenance of tension.  By comparison, the
inhibition of CAMKII only moderately reduced force development but significantly
reduced tension maintenance.  Force development but not tension maintenance was
significantly correlated with "-actin remodeling in similarly treated A7r5 smooth muscle
cells.  The results suggest that the mechanisms which regulate force development and
tension maintenance are different and are consistent with earlier proposals for a direct role
of "-actin remodel in force development.
References
Aizawa, H., M. Sameshima, and I. Yahara.  1997.  A green fluorescent protein-actin fusion
protein dominantly inhibits cytokinesis, cell spreading, and locomotion in
Dictyostelium.  Cell Struct. Funct.  22:335-345.
Akiyama, T., Ishida, J., Makagawa S., Ogawara, H., Watanabe S., Itoh, N., Shibuya M.,
and Fukami Y.  1987.  Genistein, a specific inhibitor of tyrosine-specific protein
kinase.  J. Biol. Chem.  262:5592-5595.
Batistella-Patterson, A.S., S. Wang, and G.L. Wright.  1997.  Effect of disruption of the
cytoskeleton on smooth muscle contraction.  Canad. J. Physiol. Pharmacol. 
75:1287-1299.
Bond, M. and Somlyo, A.V.  1982.  Dense bodies and actin polarity in vertebrate smooth
muscle.  J. Cell Biol.  95:403-413.
Byron, K.L.  1996.  Vasopressin stimulates Ca2+-spiking activity in A7r5 vascular smooth
muscle cells via activation of phospholipase A2.  Circ. Res.  78:813-820.
Choidas, A., A. Jungbluth, A. Sechi, J. Murphy., A. Ullrich, and G. Marriott.  1998.  The
suitability and application of a GFP-actin fusion protein for long-term imaging of
the organization and dynamics of the cytoskeleton in mammalian cells.  Eur. J. Cell
Biol.  77:81-90.
116
Di Salvo, J., G. Pfitzer, and L.A. Semenchuk.  1994.  Protein tyrosine phosphorylation,
cellular Ca2+, and Ca2+ sensitivity for contraction of smooth muscle.  Can. J.
Physiol. Pharmacol.  72:1434-1439.
Di Salvo, J., A. Steusloff, L. Semenchuk, S. Satoh, K. Kolguist, and G. Pfitzer.  1993. 
Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. 
Biochem. and Biophys. Res. Commun.  190:968-974.
Driska, S.P., M.O. Aksoy, and R.A. Murphy.  1981.  Myosin light chain phosphorylation
associated with contraction in arterial smooth muscle.  Am. J. Physiol.  240:C222-
233.
Duarte, J., M.A. Ocete, F. Perez-Vizcaino, A. Zarzuelo, and J. Tamarso.  1997.  Effect of
tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and
induction of nitric oxide synthase.  Eur. J. Pharmacol.  338:25-33.
Faix, J., C. Clougherty, A. Konzok, U. Mintert, J. Murphy, R. Albrecht, B. Muhlbauer,
and J. Kuhlmann.  1998.  The IQGAP-related protein DGAP 1 interacts with Rac
and is involved in the modification of the F-actin cytoskeleton and control of cell
motility.  J. Cell Sci.  111:3059-3071.
Firulli, A.B., D. Han, L. Kelly-Roloff, V.E. Katelionsky, S.M. Schwartz, M. Olson, and
J.M. Miano.  1998.  Comparative molecular analysis of four rat smooth muscle cell
lines.  In Vitro Cell Dev. Biol.-Animal.  34:217-226.
Fultz, M.E., C. Li, W. Geng, and G.L. Wright.  2000.  Remodeling of the actin
cytoskeleton in the contracting A7r5 smooth muscle cell.  J. Mus. Res. Cell Motil.
21:775-787.
Gabella, G.  1976.  The force generated by visceral smooth muscle.  J. Physiol. (Lond). 
263: 199-213.
Gokita, T., Y. Miyauchi and M.K. Uchida.  1994.  Effects of tyrosine kinase inhibitor and
phosphotyrosine-phosphatase inhibitor, orthovanadate on Ca2+ free contraction of
uterine smooth muscle of the rat.  Gen. Pharmac.  25:1673-1677.
Gordon, A.M., A.F. Huxley, and F.J. Julian.  1966.  The variation in isometric tension
with sarcomere length in vertebrate muscle fibers.  J. Physiol. (Lond.).  184: 170-
192.
Haller H., J.I. Smallwood, and H. Rasmussen.  1990.  Protein kinase C translocation in
intact vascular smooth strips.  Biochem. J.  270:375-381.
Kimes, B.W. and B.L. Brandt.  1976.  Characterization of two putative smooth muscle cell
lines from rat thoracic aorta.  Exp. Cell Res.  98:349-366.
117
Mehta, D. and S.J. Gunst.  1999.  Actin polymerization stimulated by contractile activation
regulates force development in canine tracheal smooth muscle.  J. Physiol.  (Lond). 
519:829-840.
Merkel, I.A., L.M. Rivera, D.J. Colussi, and M.H. Perione.  1991.  Protein Kinase C and
vascular smooth muscle contractility: Effects of inhibition and down-regulation.  J.
Pharmacol. Exp. Ther.  257:134-140.
Merkel, L., W.T. Gerthoffer, and T.J. Torphy.  1990.  Dissociation between myosin
phosphorylation and shortening velocity in canine trachea.  Am. J. Physiol. 
258:C524-C532.
Murphy, R.A.  1976.  Contractile system function in mammalian smooth muscle.  Blood
Vessels.  13: 1-23.
Murphy, R.A., J.T. Herliky, and J. Meyerman.  1974.  Force-generating capacity and
contractile protein content of arterial smooth muscle.  J. Gen. Physiol.  64: 691-
705.
Nakajima, S., M. Fujmoto, and M. Veda.  1993.  Spatial changes of [Ca2+]i and contraction
caused by phorbol esters in vascular smooth muscles.  Am. J. Physiol.  265:C1138-
C1145.
Noegel, A.A. and M. Schleicher.  2000.  The actin cytoskeleton of Dictostelium: a story
told by mutants.  J. Cell Sci.  113:759-766.
Okada, A., R. Lansford, J.M. Weimann, S.E. Fraser, and S.K. McConnell.  1999.  Imaging
cells in the developing nervous system with retrovirus expressing modified green
fluorescent protein.  Exp. Neural.  156:394-406.
Paul, R.J.  1983.  Functional compartmentalization of oxidative and glycolytic metabolism
in vascular smooth muscle.  Am. J. Physiol.  244:C399-409.  
Rice, R.V., J.A. Moses, G.M. McCanus, A.C. Brady, and L.M. Blask.  1970.  The
organization of contractile filaments in mammalian smooth muscle.  J. Cell Biol. 
47: 183-196.
Rokolya, A. and H.A. Singer.  2000.  Inhibition of CaM Kinase II activation and force
maintenance by KN-93 in arterial smooth muscle.  Am. J. Cell.  Physiol. 
278:C537-C545.
Shimamoto, Y., H. Shimamoto, C.Y. Kwan, and E.E. Daniel.  1993.  Differential effects
of putative protein kinase C inhibitors on contraction of rat aortic smooth muscle. 
Am. J. Physiol.  264:H1300-H1306.
Singer, H.A., C.M. Schworer, C. Sweeley, and H. Benscoter.  1992.  Activation of protein
kinase C isozyme by contractile stimuli in arterial smooth muscle.  Arch. Biochem.
Biophys.  299:320-329.
Singer, H.A. and K.M. Baker.  1987.  Calcium dependence of phorbol 12, 13 dibutyrate-
induced force and myosin light chain phosphorylation in arterial smooth muscle.  J.
Pharmacol. Exp. Therapeutics.  243:814-821.
Solway, J., J. Seltzer, F.F. Samaha, S. Kim, L.E. Alger, Q. Niv, E.E. Morrisey, H.S. Ip, H,
and M.S. Parmacek.  1995.  Structure and expression of a smooth muscle cell-
specific gene SM22 alpha.  J. Biol. Chem.  270:13460-13469.
Somlyo, A.V.  1980.  Ultrastructure of vascular smooth muscle.  In Handbook of
Physiology, the Cardiovascular System vol. II, Vascular Smooth Muscle, Bethesda,
MD, Am. Physiol. Soc.  pp 33-68.
Srivastava, A.K., and J. St-Louis.  1997.  Smooth muscle contractility and protein tyrosine
phosphorylation.  Mol. Cellular Biochem.  176:47-51
Tolloczko, B., F.C. Tao, M.E. Zacour and J.G. Martin.  2000.  Tyrosine Kinase-dependent
calcium signaling in airway smooth muscle.  Am. J. Physiol.  278:L1138-L1145.
VanBuren, P., W.H. Guilford, G. Kennedy, J. Wu, and D.M. Warshaw.  1995.  Smooth
muscle myosin: a high force-generating motor.  Biophys. J.  68:2588-2598.
Vandekerckhoue, J. and K. Weber.  1981.  Actin typing on total cellular extracts:a highly
sensitive protein-chemical procedure able to distinguish different actins.  Eur. J.
Biochem.  113:595-603.
Wright, G.L. and A.S. Battistella-Patterson.  1998.  Involvement of the cytoskeleton in
calcium-dependent stress relaxation of rat aortic smooth muscle.  J. Mus. Res. Cell
Motil.  19:405-414.
Wright, G. and E. Hurn.  1994.  Cytochalasin inhibition of slow tension increase in rat
aortic rings.  Am. J. Physiol.  267: H1437-H1447.
Yamada, H. and K.N. Bitar.  1995.  Phospholipase A2-activating peptide induced
contraction of smooth muscle is mediated by protein kinase C-MAP kinase
cascade.  Biochem. Biophys. Res. Comm.  217:203-210.
Zhang, Y., and R.S. Moreland.  1994.  Regulation of Ca2+-dependent ATPase activity in
detergent skinned vascular smooth muscle.  Am. J. Physiol.  36:H1032-H1039.
119
Chapter 5. General Conclusions
General Discussion
Battistella-Patterson et al. (1997) proposed that the broad length-tension relationship,
slow force development, and the low energy cost of maintained tension in smooth muscle
could be explained by remodeling of the actin cytoskeleton to modulate optimal
actin/myosin overlap and to form a stable system of tension bearing elements to hold the
cell in the contracted configuration.  They modeled this concept in terms of asynchronous
contraction in which it was proposed that different portions of the actin cytoskeleton
undergo alternating active contraction, tension maintenance, and remodeling.  
However, there was no direct evidence that actin reorganization was linked to the
contractile response.  Our work has lead to a number of significant conclusions that
expand upon this base of knowledge.  We have demonstrated that alpha and beta actin
undergo active remodeling during the contraction of the A7r5 smooth muscle cell.  b-
Actin is shown to undergo shortening without evidence of fiber compression or
disassembly, while a-actin undergoes extensive disassembly and subsequent reassembly
into intensely fluorescing column-like structures that extend from the base to the apex of
the cell.  We have further demonstrated that the actin cross-linking protein a-actinin
shows strong colocalization with a-actin throughout the interval of contraction and
remodeling.  The timing and extent of remodeling further suggests that active remodeling
may play a role in contraction.  We have further demonstrated that there is strong
colocalization of a-actin and type II smooth muscle myosin prior to stimulation.  Upon
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stimulation, myosin reorganization follows a-actin remodeling.  However, there is a
partial dissociation of the two proteins.  Agents that affect the structure of a-actin such as
cytochalasin and thapisigargin also affect the localization of myosin indicating a close
association between the two proteins.  These data suggest that the remodeling of a-actin/
myosin may serve to provide a structural arrangement to give maximal mechanical
advantage and allow force development in multiple directions.  The results further suggest
that a-actin is responsible for force development.  The last portion of our work begins to
elucidate the biochemical pathway involved in the PDBu induced contraction.  Inhibition
of protein kinase C (PKC) and tyrosine kinase decreased early force development in rat
aortic tissue, but had no significant effect on tension maintenance.  However, inhibition of
calcium/calmodulin kinase II (CAM kinase II) only moderately affected force
development, but significantly decreased tension maintenance in aortic rings.  At
concentrations that inhibit PKC and CAM kinase II, staurosporine significantly decreased
both tissue force development and force maintaince.  Treatment of A7r5 cells with kinase
inhibitors indicate a significant correlation between a-actin remodeling in cells and force
development in tissue, with no significant correlation between force maintaince and a-
actin remodeling.  Taken together our findings suggest that force development may be
linked to a-actin remodeling and is controlled separately from b-actin remodeling.  
This work has produced a modified model of cytoskeletal remodeling during
vascular smooth muscle contraction (Appendix A, Li et al., 2001) from that first proposed
by Batistella-Patterson et al. (1997).  In the stimulated cell, a-actin/ myosin and b-actin are
segregated into separate functional domains (Appendix A, A).  Immediately following
agonist stimulation, increased intracellular-calcium levels induce a-actin/myosin
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contraction (Appendix A, B) and is responsible for the fast-phase of contraction.  This
changes the stress on the b-actin fibers and, in turn, initiates b-actin cable shortening
(Appendix A, C) to preserve the tension gained.  a-Actin and myosin may then remodel to
allow maximum mechanical advantage of the contractile proteins (Appendix A, E-F). 
Eventually, equilibrium between force generation and the opposing load would result in a
plateau of active tension generation (Appendix A, G) and would be characterized by a low
level of remodeling and lock-up of the proteins.  This model predicts a high capacity to
generate force by modulation of mechanical advantage of the contractile proteins, slow
force development, and low energy cost during tension maintenance.
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Future Research
The kinase inhibitor studies performed in our laboratory have primarily focused
upon the a-actin cytoskeleton.  Work is still needed to characterize which pathways are
involved in remodeling of the b-actin cyctoskeleton.  CAM kinase II is a likely candidate
to affect b-actin is based on its effects on tension maintaince.  If a- and b-actin are
functionally compartmentalized, one would expect that distinct biochemical pathways are
involved in the remodeling of each isoform.
                  Contraction of tracheal smooth muscle has been shown to induce the tyrosine
phosphorylation and subsequent activation of focal adhesion kinase (FAK) (Tang et al.,
1999).  Phosphorylation levels of FAK was also shown to correlate with tension
development during muscarinic stimulation.  Antisense to FAK, to deplete protein levels,
reduced force development, intracellular calcium levels, and myosin light chain
phosphorylation levels in response to muscarinic stimulation (Tang and Gunst, 2001). 
Preliminary work in our laboratory indicates that FAK is present in A7r5 cells and
colocalizes with "-actin and possibly $-actin before and after phorbol contraction.  In
collaboration with Dr. Donald Primerano, we have developed a fluorescently labeled
antisense oligonucleotide to FAK.  This will allow studies on individual cells and aid in
the understanding of the role of FAK in A7r5 smooth muscle cells during contraction.
Several actin binding proteins have been identified that can affect the
polymerization state of actin filaments.  Gelsolin is a Ca2+-regulated actin severing protein
that is present in relatively high amounts in smooth muscle.  (Hinnsen et al., 1984).  After
severing the actin filament, gelsolin remains bound to the rapidly polymerizing end and
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may promote nucleation (Janmay et al., 1985; Hinnsen et al., 1984).  Gelsolin has also
been shown to stimulate myosin ATPase activity (Dabrowska et al., 1996).  Recently,
Grem and Wegner (2000) concluded that  the capping and severing functions of gelsolin
differ in their calcium affinity.  Thus, gelsolin may be a major contributor to actin
remodeling during contraction.  Other actin binding proteins, especially the actin
depolyermerizating factor (ADF) /cofilin family, may be responsible for actin remodeling
in motile cells and are deserving of further study (Bamburg, 1999).
In addition to it kinase activity, myosin light chain kinase (MLCK) is reported
to bind smooth muscle actin (Dabrowska et al., 1982; Sellers et al., 1984, Ye et al., 1997). 
Two actin binding sites may serve to cross-link actin in a Calcium/Calmodulin (Ca2+/CaM)
sensitive manner (Hayakawa et al., 1999).  Utilizing peptide fragments, the actin binding
sites were further characterized, indicating one is Ca2+/CaM-sensitive and one is
Ca2+/CaM-insensitive (reviewed in Gao et al., 2001).  Our laboratory is currently 
collaborating with Dr. Kazuhiro Kahoma to further investigate MLCK’s involvement in
actin bundling and its possible role in active remodeling during contraction.  Preliminary
studies indicate that selectively blocking the Ca2+/CaM-sensitive actin binding site results
in disassembly of actin bundles in resting and contracted tissues.
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